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Abstract 
Magnetic resonance imaging (MRI) is used for characterization and diagnosis of 
head and neck tumors as well as staging and monitoring the treatment response of 
patients with cancer. The anatomical information provided by conventional MRI 
lacks specificity in characterizing head and neck tumors and in monitoring cancer 
response to treatment. New, non-invasive MRI techniques, such as Diffusion-
Weighted Imaging (DWI) and Chemical Shift Imaging (CSI), which look at tumor 
function rather than morphology, have the potential to improve accuracy in the MRI 
evaluation of head and neck tumors. However, in the head and neck region local 
magnetic susceptibility differences between tissues cause magnetic field 
inhomogeneity resulting in severe susceptibility artifacts which cause image 
distortion in DWI and spectral peak broadening in CSI. Recently some of the 
problems with susceptibility artifact have been overcome for DWI and this technique 
has developed to the stage where it can be used as a research tool in the head and 
neck. On the other hand, CSI has yet to be developed to the stage where it produces 
data of sufficient quality for research. The two main aims of this thesis are to (1) 
evaluate the role of DWI in characterizing head and neck cancers with an emphasis 
on nasopharyngeal carcinoma which occurs at the skull base in an area that is prone 
to susceptibility problems and (2) develop a method to improve CSI so that it can 
produce functional data of sufficient quality to allow it to be used as a research tool. 
DWI was performed on patients with nasopharyngeal carcinoma (NPC) to determine 
the apparent diffusion coefficient (ADC) of the primary cancer and the metastatic 
nodes. The ADC of the primary NPC was compared with two other common 
primary head and neck cancers, squamous cell carcinoma (SCC) and non-Hodgkin，s 
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lymphoma (NHL) to determine if the ADC could be used to differentiate between 
these three cancers. In order to develop a method to improve the local magnetic field 
homogeneity for CSI, an anti-susceptibility device and different shimming methods 
were tested using a custom-made phantom containing Choline compound samples. 
The optimized sequence was then used to try to obtain functional data in patients 
with head and neck tumors. 
The results showed that DWI is a feasible technique for examining head and neck 
cancers, even at sites that suffer from susceptibility artifacts such as the skull base. 
The mean ADC value for primary NPC was 0.984 士 0.161 10-3 mm2/s which was 
significantly different (p < 0.001, Kruskal-Wallis test) from SCC and NHL ADC of 
1.14 ± 0.196 x 10-3 mm2/s and 0.746 ± 0.19 x10-3 mm2/s respectively, suggesting that 
the technique may be useful in the characterization of head and neck cancers. For 
CSI, the results showed that local magnetic field homogeneity could be improved by 
employing an anti-susceptibility device and applying a second-order shimming 
method. This resulted in substantial improvement in spectral linewidth and for the 
first time allowed CSI to be successfully employed in the head and neck producing 
functional data on the distribution of choline containing compounds (Cho) in patients 
with head and neck tumors. These preliminary results showed that CSI may have the 
potential to guide biopsies of head and neck tumors as well as may be useful in the 
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Chapter 1: Introduction, problems and objectives 
1.1 Introduction 
Cancer in the head and neck region accounts for approximately 5% of all adult 
cancers and are an important cause of morbidity and mortality. Medical imaging has 
a vital role in the management of head and neck cancer where it is used to detect and 
diagnosis cancer, stage and plan treatment, assess treatment response and identify 
recurrent tumors. One of these imaging techniques is magnetic resonance imaging 
(MRI). MRI is a non-invasive diagnostic imaging technique, which has been in 
clinical use since the early 1980s. MRI uses a strong magnet and radio frequency 
waves to produce images with extraordinary detail of the body's organs, tissues, 
bones and other internal body structures, without the use of ionizing radiation. It is 
based on the principle of nuclear magnetic resonance (NMR) to provide cross-
sectional images in any plane or three-dimensional images of the body that can be 
viewed from any angle. 
MRI is one of the best imaging modalities for demonstrating the extent of the head 
and neck cancers because of its multiplanar capabilities and the excellent soft tissue 
contrast and resolution. As a result, MRI has become a powerful diagnostic tool for 
evaluation of head and neck tumor patients because it provides high quality . 
morphological tumor information. However, MRI is also a very versatile technique 
which has the ability to provide functional information about tumor physiology and 
biochemistry, an advantage which is not available from other imaging modalities 
such as computed tomography (eT) and ultrasound (US). Some MR functional 
techniques are already being used to evaluate head and neck tumors, include 
magnetic resonance spectroscopy (MRS), which assesses metabolic activity, and 
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dynamic contrast-enhanced MRI (DCE-MRI), which assess tumor microcirculation 
(Arend Heerschap, 2007; Oberholzer, K. et al., 2008). Two novel functional MR 
techniques in the head and neck are diffusion-weighted imaging (DWI) and chemical 
shift imaging (CSI) and these two functional techniques are assessed in this thesis. 
DWI is highly sensitive to the diffusion of water molecules and can produce 
diffusion-weighted (DW) images by employing a pair of diffusion-sensitizing 
gradient pulses. The term diffusion refers to the thermal random motion of water 
molecules, known as Brownian motion, which results from the thermal energy 
carried by these molecules (Le Bihan, D. et al., 2006). Measurement of diffusion 
signal at different diffusion-sensitizing gradient pulses (b-values) can be used to 
calculate apparent diffusion coefficient (ADC), which is a quantitative value for the 
degree of water diffusion. Clinical application of DWI has been primarily used for 
early detection of ischemic stroke because of its high sensitivity and specificity to 
acute ischemic stroke (Schaefer, P. W., 2001). Recently, DWI with ADC 
measurement is gaining interest for assessing cancers and tumor cellularity in the 
brain and body. 
Single voxel proton magnetic resonance spectroscopy SV 'H-MRS can detect a wide 
variety of proton-containing metabolites in tumors, such as N -acetylaspartate, 
choline, creatine, lactate, and citrate (Catherine Westbrook et al., 2005; Payne, G. S. 
and Leach, M. 0., 2006; Robin de Graaf, 2004). This metabolic information is 
displayed as a spectrum. 
Chemical shift imaging (CSI) takes the SV MRS technique a step further and 
provides images which map the spatial distribution of specific metabolites. CSI 
obtains localized spectra from multiple adjacent voxels based on the MRS and then 
uses them to form metabolite maps of specific metabolites in large heterogeneous 
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lesions. CSI is also known as magnetic resonance spectroscopy imaging (MRSI) and 
it has been used for the evaluation of tumors in the brain, breast and prostate but not 
in the head and neck. 
1.2 Problems 
DWI and CSI techniques depend on the MRI method to create images but DWI and 
" CSI both require a very high degree of magnetic field homogeneity over the region 
of interest. The human neck contains many air/soft tissue interfaces which cause 
susceptibility differences that readily disturb magnetic field homogeneity over the 
region of the head and neck, resulting in artifacts that degrade the functional data. 
DWI will suffer from severe susceptibility-induced image distortion, particularly in 
region of skull base. For CSI, the technique will suffer from the spectral peak 
broadening and poor spatial resolution, and at present current CSI techniques have 
not been developed to work in the head and neck. 
1.3 Objectives 
In this study the two main objectives are as follows; 
1. To evaluate the role ofDWI in the characterization of head and neck cancers 
with an emphasis on nasopharyngeal carcinoma that occurs at the skull base 
in a challenging region for MR imaging. 
2. To develop a CSI method to improve magnetic field homogeneity over the 
head and neck region, so that CSI can produce functional data of sufficient 
quality to allow it suitable for clinical applications in the head and neck. 
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Chapter 2: Background 
2.1. Head and Neck Cancer 
Worldwide, it is estimated that more than 500 000 people are diagnosed with head 
and neck cancer per year (Karen Belkic, 2004). In the United States, head and neck 
cancer accounts for approximately 50/0 of adult cancers. In Hong Kong, the annual 
/ 
incidence rates of head and neck cancer in 2006 for men and women was 
approximately 21.2 and 7.4 cases per 100, 000 people, respectively (Hong Kong 
Cancer Registry, 2008). The incidence rates are more than twice as high in men as in 
women, and are greatest in men who are older than 50 (American Cancer Society, 
2006). The incidence rate of head and neck cancer tends to increase with age and 
head and neck cancer has become a public health problem for aging populations. 
The long-term use of tobacco and alcohol are two of the main causative factors for 
head and neck cancer. Other risk factors for head and neck cancer include genetic 
factors and other cancer-causing substances. 
Cancers of the head and neck comprise a heterogeneous group of malignancies. The 
most common head and neck malignancies are squamous cell carcinomas (SCC), 
usually arising in the upper aerodigestive tract (Quon, H. et al., 2001). 
Nasopharyngeal carcinomas (NPC) and malignant lymphomas (ML) are other less 
common types of head and neck malignancies. NPC develops in the nasopharynx 
and often invades the skull base. NPC is highly prevalent in southern China, but 
uncommon in western countries (Her, C., 2001). It is believed that NPC is 
associated with Epstein-Barr virus (EBV) infection. ML are neoplasms of lymphoid 
cells, divided into Hodgkin lymphomas (HL) and non-Hodgkin lymphomas (NHL) 
4 
(Atul B. Mehta and A. Victor Hoffbrand, 2000). The primary site ofML may 
involve nodal or extranodal sites (Vega, F. et aI., 2005). 
Malignant tumors of the head and neck are often fast growing cancers that tend to 
spread locally to adjacent tissues and metastasize to lymph nodes and distant sites. 
Patients with head and neck tumors may experience symptoms at the primary site 
such as a lump, pain, bleeding or loss of function or they may only become aware of 
the problem once the disease has spread to nodes in the neck. 
Early stage head and neck cancer (stage I and II) is curable in 60% to 950/0 of patients 
(Bruce Brockstein and Gregory Masters, 2003). The standard treatment options 
include surgery and/or radiation therapy. For patients with advanced-stage cancer, 
chemotherapy combined with radiotherapy can be used to control cancer growth and 
decrease the risk of cancer spread, as well as preserve function (F orastiere, A. A. et 
at., 2003; U rba, S. G. et at. , 2000). 
2.2 Diagnostic Imaging of Head and Neck Cancer 
The management of patients with head and neck tumor depends on patient history, 
clinical examination, biopsy and medical imaging. Medical imaging is used to detect 
and diagnose cancer, stage and plan treatment, assess treatment response and identify 
recurrent tumors. Medical imaging is performed because it provides a safe, rapid and 
reliable approach to managing cancer of the head and neck. Commonly used 
imaging modalities are ultrasound (US) ~ computed tomography (CT) and magnetic 
resonance imaging (MRI) which provide anatomical information. They show the 
normal structures in the head and neck and provide morphological information on 
tumor size, shape, extent and pattern of contrast enhancement. They also guide 
biopsy to confirm the diagnosis of head and neck cancer. Of these techniques MRI is 
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one of the best for demonstrating the extent of the head and neck cancers because of 
its multiplanar capabilities and the excellent soft tissue contrast and resolution. It 
also can see deep structures not identified by ultrasound, does not involve ionizing 
radiation used to produce CT images and because it is a versatile technique it can 
also provide functional data. Another technique in clinical use is positron emission 
tomography with fluorine-18 fluorodeoxyglucose (18FDG PET) which provides 
functional information but has the draw back that it needs to be combined with CT 
for anatomical data. 
Staging is important for the management of head and neck cancer because it provides 
prognostic information on patients with head and neck cancer. This information can 
be used to determine effective treatment options for head and neck cancer as well as 
predict outcome in patients with head and neck cancer. Clinically, staging is 
determined with the tumor-node-metastasis (TNM) system, which is based on the 
American Joint Committee on Cancerl International Union Against Cancer 
(AJCC/UICC) TNM classification system (Frederick L. Greene et aI., 2006). The 
TNM staging system includes the T -stage to determine the local invasion and tumor 
size, the N-stage to determine the degree of involvement of the lymph nodes, and the 
M-stage to identify the presence of distant metastasis. Staging by palpation is well 
known to be an inaccurate method because palpation is unable to assess small, deep 
mobile lesions in the head and neck region, especially the neck lymph nodes, 
including the retropharyngeal nodes and the most superior internal jugular nodes 
(Lam, W. W. et al., 1997). Staging therefore is highly dependent on imaging. 
Over the past decades, the management of head and neck cancer has improved 
significantly due to the improvement in therapy as well as the advancements and 
refinements in imaging techniques for monitoring therapy. Conventional imaging 
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modalities usually provide morphological information for the management of head 
and neck cancer patients. Conventional CT and MRI depend on changes in tumor 
size to assess tumor response to treatment. The size of tumor can be measured using 
the following measurements: bi-dimensional measurements (BDM) from the World 
Health Organization (WHO) guidelines which are obtained by the product of the two 
greatest perpendicular diameters of the tumor (Miller, A. B. et aI., 1981), uni-
dimensional'measurements (UDM) from the Response Evaluation Criteria in Solid 
Tumors (RECIST) guidelines which are obtained by taking the single greatest 
diameter of tumor (Therasse, P. et aI., 2000), and tumor volume measurements which 
are determined with the sum oftumor areas (Suresh K. Mukherji et aI., 2004). Under 
WHO and RECIST guidelines, imaging of tumor response is determined by a 
reduction of tumor size during treatment or after treatment in head and neck cancer, 
and any aggressive tumor that enlarges or fails to reduce the tumor size significantly 
may be considered to fail to response to treatment. Unfortunately change in size 
does not always reflect the true cancer response and so recently, functional imaging 
techniques have been gaining interest for monitoring tumor response to treatment. 
Positron emission tomography with fluorine-I 8 fluorodeoxyglucose (18FDG PET), as 
a functional imaging technique, provides metabolite information regarding changes 
in glucose metabolism in cancer cells (Catherine Castaigne et al., 2008) and is 
already in routine clinical practice for assessing tumor response to therapy in patients 
with head and neck cancer (Brun, E. et al., 2002; Kostakoglu, L. and Goldsmith, S. l., 
2004), but as stated above it does not provide any anatomical data. In this respect 
new MRI based functional techniques have the advantage that they can be performed 
at the same time as the usual MRI examination which produces anatomical 
information. 
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2.3. Magnetic Resonance Imaging- Physics 
2.3.1 Nuclear Magnetic Resonance Principle 
Nuclear magnetic resonance (NMR) is a physical phenomenon that is observed only 
in nuclei with odd numbers of nucleons having an intrinsic property called spin. In 
the presence of an external magnetic field, the spinning nuclei have tendency to align 
their axes along the lines of magnetic field. However, the alignment is not exact, 
which produces a wobbly rotation around the magnetic field. This wobbly rotation 
causes the spin-up and spin-down nuclei to precess around the direction of the 
magnetic field ( Bo ) at a precessional frequency (Figure 2.1). The precessional 
frequency, which is called the Larmor frequency, is unique for each type of nuclei. 
Radiofrequency (RP) energy is also applied to excite these nuclei in the presence of 
the magnetic field. The excited nuclei will resonate at a specific frequency according 
to the type of nuclei. For resonance of specific type of nuclei to occur, RP energy 
must be applied at exactly the Larmor frequency of that type of nuclei. Typical 
nuclei used in NMR are, for example, hydrogen (lH), carbon (l3C), fluorine (19F), 
sodium (23Na) or phosphorus e1p) (Alessandro Lascialfari and Corti, Maurizio, 2007; 
Catherine Westbrook. and Roth, Carolyn Kaut, 2005; Gary Liney, 2006; Schaeffter, 
T. and Dahnke, H., 2008). 
2.3.2 Proton Magnetic Resonance Imaging 
The hydrogen nucleus is the most commonly used in clinical MRI because it is 
highly abundant in the human body. A hydrogen atom with a positively charged 
proton generates a magnetic field, which is called magnetic moment ( B). The 
magnetic moment acts like a small magnet with magnetic north and south poles, 
called a magnetic dipole (Figure 2.2). When I H nuclei are placed in a static magnetic 
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field (Bo), the magnetic dipoles align either parallel or anti-parallel to Bo due to the 
two possible energy levels, known as Zeeman levels (Figure 2.3), which includes the 
lower energy level ( E\ ) and the upper energy level ( E2 ). The energy difference 
( ~ E) between these two possible energy levels is obtained by the equation: 
~ = E2 - E\ , in which ~ E is proportional to Bo and is given by the equation: 
~E = hL 130 , where h is the Planck's constant and r is the gyromagnetic ratio. 27r 
For the spinning IH nucleus, ~ E is associated with a resonance frequency in the 
radio-frequency (RF) range, given by the equation: ~E = h 0)0 ,in which transitions 
27r 
between these two possible energy levels can be stimulated by energy at this 
resonance frequency called the Larmor frequency (0)0)' which is given by the 
Larmor equation: 0)0 = rBo . 
In the static magnetic field, the alignment of the hydrogen nuclei occurs as a result of 
generating a net magnetic moment, which is called a magnetization (Mo) in the 
direction of Bo. The magnetization can be turned from one direction to another 
direction by applying a RF pulse that has exactly the same frequency as the Larmor 
frequency of hydrogen (0)0) and a magnetic field (BI ) perpendicular to Ba (Figure 
2.4). The angle between M o and Ba is called the flip angle, of which magnitude is 
determined by the type ofRF pulse energy that is applied. For an example, a 90° RF 
pulse is applied as a result of a 90° flip angle of the magnetization (Mo ). 
MR signals are usually collected by using the MR receiver coils. When coherent or 
in phase magnetization cuts across the coil, it will induce a current or voltage, which 
is known as the source of magnetic resonance (MR) signal. When the RF pulse 
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energy is switch off, relaxation occurs in which some of the nuclei at high energy 
level will give off energy in the form of radio wave and return to their lower energy 
level. This causes the magnetization to return to the original alignment with Bo , thus 
generating the free induction decay (FID) signal. In the MRI system, the FID signal 
is converted from time domain to frequency domain using a F ourier transform 
(Figure 2.5). This frequency domain signal provides an easy method to determine 
the amplitude of each frequency component. 
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Figure 2.2: The spinning proton acts as a small magnet. 
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Figure 2.3: Zeeman diagram. 
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Figure 2.5: The Fourier transform of a free induction decay signal. 
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2.3.3 Relaxation 
Relaxation is the process by which the magnetic moments return to realign to the 
static magnetic field by releasing the absorbed RF pulse energy (Mark A. Brown and 
Richard C. Semelka, 2006). This process of relaxation has two independent time 
constants, known as the spin-lattice (Tl) and the spin-spin (T2) relaxation time. The 
Tl relaxation time represents the time needed for the longitudinal component of the 
magnetization to recover 63% of its original length, whereas the T2 relaxation time 
represents the time needed for the transverse component of the magnetization to 
return to 370/0 of its original length. 
2.3.4 Tl- and T2-weighted Imaging 
Each tissue has a specific relaxation time and proton density, thereby MRI has the 
ability to produce different types of image contrast, or so-called, weighting (Mori, S. 
and Barker, P. B., 1999). The Tl-contrast mainly depends on the differences in the 
T 1 relaxation times between tissues, whereas the T2-contrast mainly depends on the 
differences in the T2 relaxation times between tissues. In Tl-weighted (Tl W) 
imaging, a tissue with short Tl relaxation time, such as fat tissue, shows high 
intensity signal on the Tl W image, and vice versa. On the other hands, a tissue with 
long T2 relaxation time, such as water, shows high intensity signal on the T2W 
image, and vice versa. The proton density contrast is related to the number of 
excited protons per unit tissue. Tissue with a high proton density, such as brain 
tissue, tends to produce a high signal intensity compared with tissue with a low 
proton density, such as bone tissue. 
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2.3.5 Difftlsion Weighted Imaging (DWI) 
Diffusion is random motion of water molecules in biological tissues, known as 
Brownian motion, resulting from thermal energy (T. Scarabino et aI., 2006). This 
motion is constant but dependent on temperature and the surroundings. In biological 
tissues, diffusion is not entirely random, but restricted by the tissue strictures. Subtle 
changes in tissues components, such as cell walls, membranes, intracellular organs, 
macromolecules, can limit or restrict the degree of water diffusion. In many tissues, 
diffusion is restricted in all directions and the process is called isotropic diffusion. In 
some highly structured tissues, such as cerebral white matter and muscle, diffusion is 
anisotropic due to restricted diffusion along one particular direction. It is usually 
considered and has been shown that tumor diffusion is isotropic (Andrzej Dzik-
lurasz and Simon Doran, 2006). 
Diffusion-weighted imaging (DWI) is a nuclear magnetic resonance (NMR) 
technique based on the phenomenon of diffusion. DWI is highly sensitive to 
molecular movement and has the ability to evaluate the diffusion of water molecules. 
It is commonly performed by adding a pair of strong magnetic field gradients to the 
MRI pulse sequence, making it sensitive to diffusion of water molecules (Heidi 
10hansen-Berg and Timothy E. 1. Behrens, 2009). These additional gradients with 
equal amplitude but opposite gradient direction are applied before and after the 1800 
pulse (Figure 2.6). The first gradient is used to dephase the water molecules, causing 
them to acquire phase shifts, and the second gradient is used to rephase the dephased 
spins. For no net movement of water molecules, the phase shift caused by the first 
gradient will be cancelled out by the second gradient, producing a strong signal. For 
net movement or diffusion, on the other hand, the dephased spins are not completely 
refocused by the second gradient, resulting in incomplete spin rephasing and thereby 
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signal attenuation (Wen -Yih Isaac Tseng and Li-Wei Kuo, 2008). The diffusion 
induced signal attenuation is given by the equation: S~b) = e-bD , where So is the 
o 
signal intensity without the gradient application, S(b) is the signal intensity with the 
gradient application and D is a diffusion coefficient, which is referred to as apparent 
diffusion coefficient (ADC) measured in biological tissues (Mori, S. and Barker, P. 
B., 1999). The b value is a gradient factor related to the gradient strength ( G ), the 
duration of each gradient pulse ( 5) and the time between the beginning of the two 
gradient pulses (~) , according to this equation: b == y 2G 2 5 2 (~ - 5) where y is the 
3 
gyromagnetic ratio (Bammer, R. , 2003). The isotropic diffusion image (DW) is 
created by simply averaging DW images acquired with the diffusion sensitizing 
gradient along the readout, phase-encoding, and section-selection directions (Le 
Bihan, D. et al., 1988). For mapping of ADC, the DW images with at least two 
different b values are required. The ADC value derived from ADC map is calculated 
with a linear least-squares regression method by using this equation: 
In S(b) == -(ADC) x b. The slope of the linear regression line describes the ADC 
So 
value (Koh, D. M. and Collins, D. 1. , 2007). To reduce the estimation error in the 




Figure 2.6: A pulsed gradient spin echo sensitized to diffusion. 
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2.3.6 Magnetic Resonance Spectroscopy- Single Voxel Spectroscopy 
and Chemical Shift Imaging 
Single Voxel Magnetic Resonance Spectroscopy 
Chemical shift is a phenomenon that occurs because the circulating electron cloud 
around an atomic nucleus generates a magnetic field that tends to oppose or shield 
the nucleus from the external magnetic field. This shielding effect causes a subtle 
difference in the magnetic field at the nucleus, and thus leading to the resonance to 
shift slightly to a different frequency. This small difference in resonance frequencies 
depending on the chemical environment is called chemical shift. Single voxel 
magnetic resonance spectroscopy (SV MRS) is also called nuclear magnetic 
resonance spectroscopy (NMRS), which is a NMR technique based on the chemical 
shift phenomenon. MRS is sensitive to the chemical environment of the nuclei and is 
able to probe the chemical structure of molecules. MRS uses RP pulses and a strong 
magnetic field to obtain the signal of nuclei from the region of interest (ROI). The 
MRS signal is displayed as a frequency spectrum in a single voxel, which shows 
signal intensity versus chemical shift between different molecules. The chemical 
shift is caused by the fact that a weak magnetic field generated by the nucleus tends 
to shield the nucleus from the external magnetic field, and thus generates a net 
magnetic field strength ( Bi ) at the nucleus, which is defined by the equation: 
Bi = Bo (1- CYi), where CYi is the shielding factor for nucleus i (Nouha Mikhael 
Salibi and Mark A. Brown, 1998). Because nuclei (e.g. protons) in different 
chemical environments and locations experience different magnetic field strengths 
(Brateman, L., 1986), the resonant frequency of each spin will be different, 
depending on the amount of local nuclear shielding that depends on the electron 
density around a nucleus (Lindsay T. Byrne, 2008). Therefore, the resonant 
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frequency as indicated by the Larmor equation must also be modified into this form: 
UJ; = yBo (1 - (J; ), where UJ; is the frequency for the ith spin. This modified Larmor 
equation shows that the resonant frequency of a spin will shift depending on the 
magnetic field strength as well as its chemical environment. In this case, the shift of 
resonant frequency is referred to chemical shift. The chemical shift ((J;), generally 
expressed in parts per million (ppm), is defined by the equation: 
(J; = (UJ; - OJrej )/ UJrej , where UJrej is the resonant frequency for the reference nuclei. 
The chemical shift is very small but useful to identify different molecules. A 
functional group or chemical compound containing one or more spins will have a 
unique chemical shift, which is referred to a specific position of the spectrum. This 
specific position of a given resonant peak is usually given with respect to a reference 
peak (Edward F. Jackson, 2001). We can therefore determine the structure of a 
molecule by measuring the position of the resonance peak in the spectrum. Table 2.1 
(adapted from Payne, G.S. and Leach, M. 0.,2006; Catherine Westbrook et aI., 2005; 
Robin de Graaf, 2004) shows the proton chemical shifts corresponding to specific 
metabolites in human tissues. MRS, thus can determine the differences between 
chemical compounds in which the spins are present. 
Water Suppression 
In proton MRS, the magnetization of water is much larger than the magnetization of 
all metabo li tes of interest, and therefore the water signal giving a very broad line 
shape overlaps the neighboring signals from the metabolites (Klose, U., 2008). This 
causes the metabolite peaks undetectable in the spectrum. For this reason, the most 
common approach is to suppress the water signal using a frequency selective, 90° 
pulses, which is called chemical shift-selective water suppression (CHESS) pulses. 
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IH chemical 
shift of main 
Metabolite peak (ppm) 
Choline-containing 
compounds (Cho) 3.2 
Description 
The signal of choline consists of 
choline, phosphocholine and 
glycerophosphorylcholine. Cho are 
related to cellular membrane 
turnover. 
Creatine (Cr-PCr) 3.0 
Cr contains creatine and 
phosphocreatine and it plays a role in 
the energy metabolism. 
Citrate (Cit) 2.6 
N-acetylaspartate (NAA) 2.0 
Lactate (Lac) 1.3 
Cit is synthesized and accumulated 
by normal prostate cells. 
NAA is only present in brain and is 
considered a neuronal marker. 
Lac is a product of anaerobic 
glycolysis. 
Lipids (Lip) 0.9, 1.3 Lipid is often found in necrotic. 
Table 2.1: Brief details of some metabolites seen in I H spectra of human tissues 
Fat Suppression 
Lipid signal acquired from the head and neck region is also a dominant signal in a 
spectrum (Bisdas, S. et aI. , 2007; Star-Lack, J. M. et al., 2000), and it arising from 
the subcutaneous regions is about a thousand times greater than the signal of 
metabolites (Skoch, A. et aI. , 2008). To avoid lipid signal contamination from 
neighboring adipose tissues, techniques to suppress the lipid signals are often 
required. The outer volume suppression (OVS) is a suppression technique that can 
be used to suppress unwanted signals by using the OVS bands to surround ROI 
(Figure 2.7). OVS bands allow to exclude unwanted signals as well as to preserve 
the metabolic information. This OVS technique can be used to reduce lipid signal 
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contamination and contaminations from air, water, and other substances as well, and 
therefore OVS bands improve quality of CSI (R.H. Wu et aI., 2003). 
Chemical Shift Imaging 
Chemical shift imaging (CSI) is a NMR technique that combines features of imaging 
and spectroscopy (Nouha Mikhael Salibi and Mark A. Brown, 1998). CSI acquires 
spatiallocal1zed spectra from individual voxels by employing the MRS method. The 
localized spectra can then be displayed either as spectral maps that represent the 
spatial distribution of the magnetic resonance spectrum or as metabolite images that 
visualizes the spatial distribution of different metabolites of interest. Since CSI 
technique is based on the MRS method to create images or maps, CSI is also referred 
to magnetic resonance spectroscopic imaging (MRSI) or simply spectroscopic 
imaging (SI). 
MRS and CSI commonly employs localization techniques, such as point resolved 
spectroscopy (PRESS) or stimulated echo acquisition mode (STEAM) techniques, to 
acquire a localized spectrum from a single voxel or spatial localized spectra from 
multiple adjacent voxels (Donald W. McRobbie et aI., 2003; Peter B. Barker, 2005). 
Both PRESS and STEAM techniques use a series of three selective RP pulses to 
define the planes of interest (Figure 2.8). PRESS (Figure 2.9) uses a slice selective 
90° pulse followed by two 180° refocusing pulses, whereas STEAM (Figure 2.10) 
uses three 90° pulses to generate the stimulate echo. The volume localization is then 
accomplished using phase encoding techniques. Each phase-encoding gradient is 
applied to replace a slice-selection gradient. In two-dimensional (2D) single slice 
CSI, phase encoding gradients are performed in x and y directions, leaving one 
direction as a slice select. In three dimensional (3D) CSI, phase encoding gradients 
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are performed in all three directions of slice-selection. To acquire CSI, PRESS 
localization technique is generally preferred because of its superior signal to noise 
ratio (Nelson, S. J. , 2003). 
Figure 2.7: Outer volume suppression (OVS) bands (rectangles) surround the RO!. 
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Figure 2.10: The STEAM pulse sequence. TM denotes the mixing time. 
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Chapter 3: Diffusion-weighted imaging in the evaluation of 
head and neck cancer 
3.1 Introduction - Diffusion-weighted Imaging in Tumors 
Diffusion-weighted imaging (DWI) is a non-invasive imaging technique that is 
capable of characterizing tissues and producing diffusion-weighted (DW) images 
based on differences in diffusion motion of water protons in tissue. Using such D W 
images with different b values, the apparent diffusion coefficients (ADCs) can be 
calculated. The term ADC refers to a quantitative value for the degree of water 
diffusion in biological tissues. Hence, hyper-cellular tumor tissue with smaller extra-
cellular space, such as solid tumor tissue, will show low ADC values, whereas hypo-
cellular tumor tissue with larger extra-cellular space, such as necrotic or cystic 
tumors, will show high ADC values (Ross, B. D. et a!., 2003). Thus, ADC values of 
the tissues are expected to vary according to the microstructures and physiologic 
states of the tissues (Sumi, M. et a!., 2002; Wang, J. et a!., 2001). 
DWI has emerged as a powerful imaging tool, and with ADC can be used for lesion 
characterization. DWI has been applied to detect many lesions in the brain and body 
as well as it is used to help characterize lesions. It has been successfully used to 
evaluate central nervous system (CNS) disease. Previous studies have demonstrated 
the utility of DWI for the diagnosis and management of cerebral ischemia (Baird, A. 
E. et a!., 1997; Gonzalez, R. G. et a!. , 1999; Lovblad, K. O. et a!. , 1998; Schaefer, P. 
W. et a!., 2000; Sorensen, A. G. et a!., 1996; Warach, S. et a!. , 1995), for the 
detection of white matter disorders (Tanner, S. F. et a!. , 2000) and brain tumors 
(Brunberg, J. A. et aI., 1995; Filippi, C. G. et a!., 2001; Tien, R. D. et a!. , 1994), for 
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the differentiation of brain lesions (Castillo, M. et al., 2001; Kim, Y. J. et al., 1998; 
Okamoto, K. et al., 2000; Sugahara, T. et al., 1999; Tsuruda, J. S. et al., 1990), and 
for the detection of residual or recurrent tumors (Hein, P. A. et al., 2004). Promising 
results have also been obtained with DWI in regions outside the CNS for differential 
diagnosis of benign and malignant lesions in the bone marrow (Baur, A. et al., 1998; 
Maeda, M. et al., 2003), breast (Kuroki, Y. et al., 2004; Sinha, S. et al., 2002), liver 
(Kim, T. et aI, 1999; Namimoto, T. et al., 1997), and lymph nodes (Abdel Razek, A. 
A. et al., 2006; Akduman, E. 1. et al., 2008; Misa Sumi, Noriyuki, 2003), for 
characterization of cystic lesions in the ovaries (Moteki, T. and Ishizaka, H., 1999) 
and pancreas (Yamashita, Y. et al. , 1998), for evaluation of tumor response to 
therapies in bone (Hayashida, Y. et al., 2006) and rectal cancers (Dzik-Jurasz, A. et 
al., 2002), and for detection of malignant tumors in the prostate (Issa, B., 2002), 
kidney (Thoeny, H. C. et al., 2005) and urinary bladder (Matsuki, M. et al., 2007). 
3.2 DWI of Nasopharyngeal Carcinoma 
3.2.1 Introduction and Objectives 
DWI has not been performed previously on primary nasopharyngeal carcinomas 
(NPC) because of the difficulty of performing this technique in the skull base and the 
ADC value of this cancer has not been established. The primary objective was to 
evaluate the feasibility of performing DWI using the technique descried above and 
establish the normal range of ADCs for undifferentiated NPC. The secondary 
objectives were (a) to evaluate two methods for measuring ADC employing the 
whole lesion (WL) and the representative section (RS) measurement techniques and 




Head and neck cancer patients with previously untreated NPC were recruited for this 
prospective study. The research ethics committee approval was obtained and an 
informed consent was also obtained from all patients before the study. 
Histological biopsy finding was the reference standard for the primary tumor, 
whereas the reference standard for a malignant node was based on the MRI images in 
which lymph nodes were evaluated for size and morphological criteria. The several 
conditions for selection of a malignant node were as follows: (1) in each patient, only 
the largest abnormal node was selected for evaluation, (2) based on the MRI criteria 
for characterization of lymph nodes, the node was considered as a malignant node if 
it had shortest axial diameter of > 11mm in the jugulodigastric region, > 5 mm in 
the retropharyngeal region and > 10 mm in all other regions of the neck, (3) or as 
any node with necrosis or extracapsulary neoplastic spread irrespective of size (Som 
PM 1987; van den Crekel 1990; Lam WW 1997). 
DWI 
DWJ- Technique Adapted/or Use in the Head and Neck 
D WI Protocol 
In general, the isotropic diffusion-weighted CDW) image is created by simply 
averaging DW images acquired with the diffusion sensitizing gradient along the 
readout, phase-encoding, and section-selection directions (Denis Le Bihan et al. , 
1988). Many previous DWI studies of cancers have used high b values of 1000 
s/mm2, but higher b values produce more susceptibility effects in the head and neck 
region and so DWI becomes difficult to perform, especially in the skull base. Hence, 
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this study attempts to use b values only up to soo s/mm2 in order to minimize the 
susceptibility effects. For mapping of ADC, DW images with at least two different b 
values are required and many studies use the basic technique of employing only two 
or three b values, such as 0, soo and 1000 s/mm2 to produce the ADC maps. In this 
study, six b values are used for data analysis (0, 100, 200, 300, 400, and SOO s/mm2) 
in order to reduce the estimation error in the calculation of ADC. 
All examinations were performed on a 1.ST MRI scanner (lntera NT; Philips 
Medical Systems Best, the Netherlands). The MRI scanner was equipped with a 30 
mT/m maximum gradient strength for echo-planar imaging (EPI). A standard head 
and neck coil was used to include head and neck cancer arising. 
DWI employed EPI sequence. Eleven fat-suppressed DW images were acquired in 
the axial plane using a spin-echo single-shot EPI sequence (repetition time = 2000ms, 
echo time = 7S, section thickness = 4 mm, with no intersection gap, field of view = 
23 cm, acquisition matrix = 112 x 112, reconstruction matrix = 2S6 x 2S6, number of 
signals acquired = 4) with six b values of 0, 100, 200, 300, 400, and SOO s/mm2. A 
set of ADC maps with 11 sections to include the region of interests (ROls) was 
generated for data analysis 
Patients also underwent a conventional MR protocol to provide anatomical detail 
consisting of axial fat-suppressed T2-weighted turbo spin-echo (PS T2W TSE) 
(repetition time = 2500ms, echo time = lOOms, section thickness = 4mm, with no 
intersection gap, number of signals acquired = 2), axial Tl-weighted spin-echo (Tl W 
SE) (repetition time = 477ms, echo time = l2ms, section thickness = 4 mm, with no 
intersection gap, number of signals acquired = 2), and contrast-enhanced axial Tl W 
SE (repetition time = 477ms, echo time = l2ms, section thickness = 4mm, with no 
intersection gap, number of signals acquired = 2) sequences. The contrast agents 
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were administrated at a dose of 0.1 mmollkg of gadoterate meglumine (Dotarem; 
Guerbet, Aulnaysous-Bois, France). 
DWI Analysis 
Data were reconstructed with the Philips data analysis package (Philips Medical 
Systems, Best, the Netherlands). ADCs were measured using dedicated software 
(ViewForumR2.5.3, Philips Medical Systems, the Netherlands). 
Lesions greater than 6 mm in minimum diameter were analyzed using conventional 
MR images as a reference for the anatomical details, and the ROls of primary tumor 
and metastatic node were drawn manually on each section in the ADC map and their 
ADCs were measured. For each tumor ROJ, two ADC measurements were taken: (1) 
ADC of the whole lesion (WL) measurement, for which the ADC value at every 
tumor section was measured, and the mean ADC was calculated, and (2) ADC of a 
single representative section (RS) measurement, which was selected to include the 
largest solid component of the tumor and to exclude any obviously necrotic or cystic 
regIons. 
DWI was performed and analyzed using the WL and RS measurement techniques 
described above. Examples of primary and nodal tumors assessed by D WI are 
shown in figures 3.1 and 3.2. 
Statistical Analysis 
A two-tailed non-parametric Mann-Whitney U test was employed to detect any 
statistically significant difference in the mean ADC between the WL and the RS 
measurement techniques. For comparing the mean ADC of the primary NPC and 
nodal metastases, a non-parametric Mann-Whitney U test was also used. A p value 
25 
of less than 0.05 was considered to be statistically significantly different. Data were 
expressed as means ± standard deviation (SD). All statistical analyses were 
performed using SPSS, version 11.0 (SPSS, Chicago. Ill). 
Figure 3.1: Post-contrast Tl-weighted image (left) with the primary NPC (arrows) 
and ADC map (right) with the region of interest drawn around the primary NPC. 
Figure 3.2: Post-contrast Tl-weighted image (left) with the malignant node (arrows) 




DWI was performed in 79 patients (63 men and 16 woman) between 24 and 80 years 
of age (mean age ± standard derivation = 51 ± 11) with 93 newly diagnosed NPC 
(primary NPC, n = 65; malignant nodes, n = 28); ADC maps in 22 cases (primary 
NPC, n = 20; malignant nodes, n = 2) were uninterpretable due to susceptibility 
artifacts. Hence, the success rate of performing D WI in patients with the primary 
NPC at the skull base was calculated about 70% (45/65) in this study. 
ADC Values of Primary NPC and Nodal Metastases 
The average maximum axial diameters for primary NPC and nodal metastases were 
4.12 ± 1.21 cm and 1.95 ± 6.32 cm, respectively; the maximum axial diameter range 
is shown in tables 3.1 and 3.2. 
The mean ADC for primary NPC using the WL measurement was 0.985±0.157x 10-3 
mm2/s, whereas the mean ADC using the RS measurement was 0.984±0.161 x l0-3 
,.-
mm
2/s. There was no significant difference in the mean ADC between the WL and 
RS measurement techniques (p = 0.913 , Mann-Whitney U test) (Table 3.1 , Figure 3.3) 
For nodal metastases, the mean ADC using the WL measurement was 
0.885±0.1 05 xl 0-3 mm2/s , whereas the mean ADC using the RS measurement was 
0.852 ± 0.117 x 10-3 mm2/s. There was no significant difference in the mean ADC 
between the WL and RS measurement techniques (p = 0.323 , Mann-Whitney U test) 
(Table 3.2, Figure 3.4) 
Comparison of the ADC of the primary tumor and nodal metastases 
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Comparing ADCs of the primary NPC and nodal metastases, the ADC of the primary 
NPC was higher than the nodal metastases and statistical analysis showed a 
significant difference between primary NPC and malignant nodes when using both 
the WL (p = 0.008) (Figure 3.5) and the single RS measurement techniques (p 
<0.001) (Figure 3.6). 
Measurement/ Statistical values 
Mean ADC ± SD x 10-3 mm2/s 
Range of ADC x 10-3 mm2/s 
Average maximum axial diameter 
± SD (range) cm 
Measurement technique for primary NPC 
Whole Lesion Representative 
(WL) Section (RS) 
0.985±0.157 0.984±0.161 
0.59 - 1.31 0.62 - 1.34 
4.12 ± 1.21 (1.64 - 7.31) 
p-value 0.913 
Table 3.1: Primary NPC with mean and range of ADC, tumor size and p-value. 
Measurement/ Statistical values 
Mean ADC ± SD x 10-3 mm2/s 
Average maximum axial 
diameter ± SD (range) cm 
Measurement technique for nodal metastasis 
Whole Lesion 
(WL) 
0.885 ± 0.105 
0.67 - 1.08 
Representati ve Section 
(RS) 
0.852±0.117 
0.63 - 1.03 
1.95 ± 6.32 (1.02 - 3.34) 
p-value 0.323 
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Figure 3.3: A plot of ADC of primary NPC versus WL and RS measurement 









ADC of nodal metastasis versus WL and RS measurements 
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Figure 3.4: A plot of ADC of nodal metastasis versus WL and RS measurement 
techniques (p = 0.323). 
29 






t/) •• ~ 1.1 • 
•• • 00 E •• 0 •• •• CW) 1.0 • • 0 
•••• I 0000 0 ••• ~ 0.9 ••• 800g • , .. og8 0 •• ~ 0.8 •• 0000 
••• 00 
• 0.7 00 
• 
0.5 
Primary NPC Nodal metastasis 
Group 
Figure 3.5: A plot of ADC using the whole lesion (WL) measurement of primary 
NPC and nodal metastasis (p = 0.008). 
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Figure 3.6: A plot of ADC using the representative section (RS) measurement versus 
primary NPC and nodal metastasis (p < 0.001). 
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3.2.4 Discussion 
Diffusion-weighted imaging of head and neck has been used in the diagnosis of head 
and neck lesions (Abdel Razek, A. A. et aI., 2006; Friedrich, K. M. et aI., 2008; 
Kawai, Y. et aI., 2005; Misa Sumi, Noriyuki, 2003; Sumi, M. et aI., 2002; Sumi, M. 
et aI., 2006; Wang, J. et aI. , 2001; Yoshino, N. et aI., 2001), evaluation of residual or 
recurrent tumors (Aikele, P. et aI., 2003; Dubrulle, F. et aI., 2006; Vandecaveye, V. 
et aI., 2006) as well as the assessment of tumor response to chemoradiotherapy 
(Vandecaveye, V. et aI., 2007). Previous studies have demonstrated that the utility 
of ADC for differentiating between benign and malignant cervical lymph nodes (de 
Bondt, R. B. et aI., 2009; Holzapfel, K. et aI., 2009), lymphomas from carcinomas in 
the head and neck (Maeda, M. et aI. , 2003; Sumi, M. et aI. , 2007), and cysts from 
head and neck tumors (Sakamoto, 1. et aI., 2009). It has also been evaluated for 
predicting tumor response to neoadjuvant therapy for head and neck squamous cell 
carcinomas (HNSCC) (Kato, H. et aI., 2009), and for differentiating residual or 
recurrent head and neck tumors from post-ragiation or post-surgical changes (Abdel 
Razek, A. A. et al. , 2007). Recent studies suggest that ADC can be used as a marker 
for prediction and early detection response to concurrent chemoradiation therapy in 
HNSCC (Kim, S. et al., 2009). 
U sing the technique adapted to the head and neck which is described in the methods 
section, it was found that DWI is a feasible technique for examining NPC, not only 
in neck nodes, but also in the primary tumor which lies at the challenging site of the 
skull base. DWI was successfully performed in primary tumors in 70% of cases but 
it was degraded in 30% of cases by susceptibility artifacts resulting from local 
magnetic field variations at air-tissue interfaces in the region of the skull base. The 
ADC value for the primary tumor lies 0.985 ± 0.157 xl0-3 mm2/s for using the whole 
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lesion (WL) measurement technique and 0.984 ± 0.161xlO-3 mm2/s for using the 
representative section (RS) measurement technique. There was no statistically 
significant difference in the ADC value when calculating the ADC from all sections 
through the whole lesion compared to just using a single section taken at the level of 
the largest solid tumor. This is probably because most primary tumors are 
homogeneous and non-necrotic so using a single RS measurement technique can 
provide an accurate method of assessing ADC but in a more effective way which 
takes less time to draw the ROI and analyze the data. 
For nodal tumors there was an even higher success rate for DWI of about 93% (26/28) 
because of less problems with susceptibility effects. The ADC values using the WL 
and the RS measurement techniques for nodal metastases were 0.885±0.1 05 x l 0-3 
mm
2/s and 0.852±0.117x lO-3 mm2/s, respectively. Using these two measurement 
techniques, also there was no statistically significant difference in the ADC value. 
This is because not many necrotic nodes were involved in this study. Hence, the 
result in the calculation of ADC from all sections through the whole lesion was 
similar to that from a single section selected to exclude any obviously necrotic or 
cystic regions and include the largest solid component of the nodal tumor. However, 
taking the measurement from whole lesion could theoretically lead to error in lymph 
nodes with extensive necrosis, because necrotic or cystic areas tend to produce 
higher ADC values compared to non-necrotic areas. The ADC of nodal metastases 
was found to be statistically significantly lower than that of the primary tumor. The 
cause for this is uncertain but possibilities include the influence of the underlying 
normal nodal architecture on ADC or biological changes in the tumor when it 
spreads from the primary site to the neck node. 
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This study had some limitations. First, perfusion in tumor tissue can have greater 
influence on DWI obtained with low b-values (b =0, 30, and 100 s/mm2) hence may 
contribute to the ADC calculation. In this study, the ADC values of the tumors were 
therefore calculated using a relatively high b-value (500 s/mm2) to reduce the 
contribution of the perfusion factor. Second, micronecrosis may have been included 
in ROIs because it was undetected by conventional MRI. However, the necrotic foci 
are probably too small to contribute to the changes in ADC values of the tumors. 
The ability of DWI to assess the primary tumors and nodal metastases and to produce 
an ADC value provides the foundation for using ADC to differentiate NPC from 
other head and neck cancers. It also provides the potential for ADC to be used in the 
future to monitor treatment response to chemoradiotherapy. 
3.3 DWI of Primary Tumors: Comparison ofNPC with Squamous 
Cell Carcinoma and Extra-nodal Non-Hodgkin Lymphoma 
3.3.1 Introduction and Objectives 
Nasopharyngeal carcinoma (NPC), squamous cell carcinoma (SCC) and extra-nodal 
non-Hodgkin lymphoma (NHL) are common primary malignancies of the head and 
neck in Hong Kong. They may all present as a primary tumor in the nasopharynx or 
as a metastatic lymph node in the neck. The results from the previous study show 
that the ADC value ofNPC seems to lie in a narrow range and therefore by using 
ADC values of the tumor DWI has the potential to be used as a diagnostic tool to 
distinguish between these three primary site cancers. 
The aim of this study was therefore to determine if there are any significant 
differences between the ADC values of these three cancers. 
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3.3.2 Methods 
Patient Selection and D WI 
Patients with histologically confirmed undifferentiated nasopharyngeal carcinomas 
(NPC), squamous cell carcinomas (SCC), and extra-nodal non-Hodgkin lymphomas 
(NHL) were recruited and underwent DWI according to the methods in section 3.2.2 
above. Analysis of the primary tumor site was performed using the RS technique 
also described in section 3.2.2 
Statistical Analysis 
Statistical tests were performed to detect any difference between subject groups. A 
non-parametric Kruskal-Wallis test was used to detect any statistically significant 
difference in the mean ADC between three subject groups, such as NPC, SCC, and 
NHL. If a statistically significant difference (p <0.05) was found, a two-tailed non-
parametric Mann-Whitney U test with Bonferroni correction was used to assess 
difference among the three groups, and a p-value of less than 0.05 was considered 
statistically significant. When a significant difference was found between each pair 
in the subject groups, receiver operating characteristic (ROC) analysis was employed 
to investigate the discriminatory capability of the ADC value for distinguishing each 
pair. Sensitivity and specificity were assessed by the ROC, to determine optimal 
sensitivity and specificity. The value that corresponded to a specificity of 100% with 
maximized sensitivity was also evaluated. Data were expressed as means ± standard 
deviation (SD). All statistical analyses were performed using SPSS, version 11.0 




100 consecutive patients (85 men, 15 women) with newly diagnosed head and neck 
cancers (NPC, n = 65; SCC, n =28; NHL, n =7) at a primary site were recruited in 
this prospective study, of which 24 patients (NPC, n = 20; SCC, n = 2; NHL, n = 2) 
were excluded because images obtained were degraded by artifact (a flowchart 
shown in figure 3.7). This study included 76 patients (64 men and 12 women) 
between 26 and 79 years of age (mean age ± standard derivation = 53 ± 11) with 
head and neck cancers (NPC, n = 45; SCC, n = 26; NHL, n = 5). 
ADC Values ofNPC, SCC and NHL 
The mean ADC values of primary NPC, SCC and NHL were O. 984±0.161 x 10-3 
and range of the ADC and the average and range of the maximum axial diameter are 
shown in table 3.3 and examples of the three cancers are shown in figures 3.8 - 10. 
Head and neck Cancer/ Statistical Analysis 
NHL (n = 5) Mean ADC ± SD 
(Range) x l0-3 mm2/s 0.746 ± 0.192 (0.723 - 0.767) 
Average maximum axial 
diameter (Range) cm 3.4 ± 0.80 (2.11 - 4.09) 
Group NPC (n = 45) MeanADC± SD 
(Range) x l0-3 mm2/s 0.984 ± 0.161 (0.617 - 1.34) 
A verage maximum axial 
diameter (Range) cm 4. 12 ± 1. 21 (1. 64 - 7.3 1 ) 
SCC (n = 26) MeanADC± SD 
(Range) x 10-3 mm2/s 1.14 ± 0.196 (.79 - 1.51) 
A verage maximum axial 
diameter (Range) cm 4.36 ± 1.64 (1.92 - 9.48) 
Table 3.3: The ADC values for each group. 
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, Figure 3.7: A flowchart of patients with head and neck cancers. 
-
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Figure 3.8: Primary NPC in a 38-year-old woman. The axial post-contrast Tl W MR 
image (left) and ADC map (right) show a primary tumor (arrows) with the ADC 
value of 0.990 ± 0.169 x 10-3 mm2j s. 
Figure 3.9: Extra-nodal NHL in a 65-year-old man. The axial post-contrast Tl W 
MR image (left) and ADC map (right) show the primary tumor (arrows) with ADC 
value of 0.736 ± 0.20l x l0-3 mm2j s. 
Figure 3.10: Primary SCC in a 63-year-old man. The Axial fat-suppressed T2W MR 
image (left) and ADC map (right) show the primary tumor (arrows) with ADC value 
of 1.10 ± 0.324 x lO-3 mm2j s. 
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Comparison of the ADC Values of the Three Cancers 
Results of statistical analysis showed a significant difference in the mean ADC (p < 
0.001, Kruskal-Wallis test) between NPC, NHL and SCC. When comparing each 
pair, the mean ADC ofNHL was significantly lower than that ofNPC (p = 0.002) 
and SCC (p <0.001), and the mean ADC ofNPC were significantly lower (p = 0.003) 
than that of SCC (Figure 3.11, Table 3.4). 
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Figure 3.11 : A plot of the ADC versus each head and neck cancer group (p < 0.001 , 
Kruskal-Wallis test). The horizontal lines near the middle of the box represent 
median. 
Results of Mann-Whitney U test with Bonferroni correction 
Comparison of cancer groups p-value 
NPC versus NHL 0.002 
NPC versus SCC 0.003 
SCC versus NHL <0.001 
Table 3.4: Non-parametric Mann-Whitney U test with Bonferroni correction for 
paired group comparisons of ADC values 
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Results from ROC Analysis 
The optimal ADC threshold value for distinguishing between SCC and NHL, 
between NPC and SCC, and between NHL and NPC was 0.779 x 10-3 mm2/s, 1.07 x 
10-3 mm2/s, and 0.768 x 10-3 mm2/s, respectively, when we optimized both 
sensitivity and specificity (Figures 3.12 - 14, Table 3.5). 
In order to improve specificity, the results were re-evaluated to produce a threshold 
with a specificity of 100% while maximizing the sensitivity for discrimination 
between SCC and NHL, SCC and NPC, and NPC and NHL (Table 3.6). The 
following results were found. 
1) The ADC threshold for the differentiation of SCC from NHL was 0.779 x 10-
3 mm
2/s which produces a sensitivity of 1000/0. 
2) The ADC value of SCC for the prediction of differentiation from NPC was> 
1.36 x 10-3 mm2/s which produces a sensitivity of 15.40/0. The ADC value of 
NPC for the prediction of differentiation from SCC was < 0.779 x 10-3 mm2/s 
which produces a sensitivity of 8.9%. 
3) The ADC value of NPC for the prediction of differentiation from NHL was> 
0.768 x 10-3 mm2/s which produces a sensitivity of93.3%. No suitable ADC 
value was obtained to distinguish NHL from NPC because specificity can not 
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Figure 3.13: ROC curve for ADC value for discrimination between SCC and NPC. 
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Comparison AUC (95% Cl) mm2/s) SE SP PPV NPV 
1.00 (1.00 - 1.00) 0.779a 100% 100% 1000/0 1000/0 
SCC vs. NHL 1.00 (1.00 - 1.00) 0.779b 100% 100% 100% 1000/0 
0.716 (0.589- 0.843) 1.07c 65.4% 73.3% 59% 79% 
NPC vs. SCC 0.716 (0.589- 0.843) 1.07d 73.3% 65.40/0 79% 59% 
0.93 (0.86-1.00) 0.768e 93.3% 100% 100% 63.0% 
NPC vs. NHL 0.93 (0.86-1.00) 0.768 f 1000/0 93.3% 63.00/0 1000/0 
Table 3.5: The optimum ADC threshold values for distinguishing between SCC and 
NHL, SCC and NPC, and NPC and NHL with the optimal sensitivity and specificity. 
Note. - AUC = area under curve, Cl = confidence interval, SE = sensitivity, SP = 
Specificity, PPV = positive predictive value, NPC = negative predictive value. 
a ADC values greater than the ADC threshold show stronger evidence for SCC. 
b ADC values less than the threshold show stronger evidence for NHL. 
c ADC values greater than the threshold show stronger evidence for SCC. 
d ADC values less than the threshold show stronger evidence for NPC. 
e ADC values greater than the threshold show stronger evidence for NPC. 
f ADC values less than the threshold show stronger evidence for being NHL. 
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Cut off ADC value at 
a specificity of 100% 
Comparison (x 10-3mm2/s) SE SP PPV NPV 
SCC vs. Predicting SCC 0.779a 100% 100% 100% 100% 
NHL Predicting NHL 0.779b 100% 100% 100% 100% 
NPC vs. Predicting SCC 1.36a 15.40/0 100% 100% 67% 
SCC Predicting NPC 0.779c 8.9% 100% 100% 390/0 
NPC vs. Predicting NPC 0.768d 93.3% 100% 100% 63% 
NHL Predicting NHL 100% specificity unavailable (No suitable cutoff) 
Table 3.6: The cut-off ADC values for distinguishing between SCC and NHL, SCC 
and NPC, and NPC and NHL with a specificity of 100% and maximum sensitivity. 
Note. - AUC = area under curve, Cl = confidence interval, SE = sensitivity, SP = 
Specificity. 
a ADC values greater than the ADC threshold show stronger evidence for SCC. 
b ADC values less than the threshold show stronger evidence for NHL. 
c ADC values less than the threshold show stronger evidence for SCC. 
d ADC values greater than the threshold show stronger evidence for NPC. 
3.3.4 Discussion 
The objectives of this study were to evaluate the utility of ADC of undifferentiated 
nasopharyngeal carcinoma (NPC) as a diagnostic tool to distinguish this cancer from 
SCC and NHL which are two other common cancers in the head and neck in our 
study population. This in vivo DWI study de)llonstrated a statistically significant 
difference in the ADC among the three subject groups of primary cancers. The ADC 
value ofNPC was found to lie between that ofNHL and SCC with a progressive 
increase in ADC from NHL to NPC to SCC. The difference in ADC values may be 
caused by factors such as cellularity, necrosis and perfusion. Cellularity is probably 
the most important factor that influences water diffusivity in tumors. There are 
studies that have demonstrated a close correlation between ADC and cellularity in 
tumors (Guo, A. C. et aI., 2002). Cancers with greater cellularity and less extra-
cellular space have a greater restriction of diffusion and lower ADC. Lymphomas 
are tumors that are especially cellular and compact, which would account for this 
tumor having the lowest ADC value out of the three cancers in this study. Necrosis 
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may be another factor that influences water diffusivity in tumors. Good correlation 
between ADC and necrotic fraction of tumor has been shown (Lyng, H. et aI., 2000); 
the tumors with high necrotic fraction had relatively high ADC value compared to 
tumors with low necrotic fraction. However, this may not have accounted for the 
differences in this study because the necrotic portion of tumors was excluded from 
the RO I measurement in the RS measurement technique. Perfusion is a further 
possible factor that may contribute to the ADC. With b values less than 100 s/mm2, 
perfusion can influence ADC by producing pseudo-diffusion coefficient, although 
once again in this study by using a plot of from six diffusion weighted images this 
effect should have been minimal. 
Other studies have revealed a significantly lower ADC in lymphoma compared to 
SCC and these studies also highlighted the potential of using DWI for tumor 
characterization (Maeda, M. et aI. , 2005; Sumi, M. et aI., 2007). The mean ADC 
values of this study appear to be consistent with those reported by Maeda et al. 
studies (Maeda, M. et aI. , 2005) (mean ADC values were 0.96±0.11 x 10-3 mm2/s for 
SCC and 0.65±0.09x 10-3 mm2/s for lympho~as) and by Sakamoto et al. studies 
(mean ADC values were 1.38±0.42x 10-3 mm2/s for SCC and 0.80±0.12x 10-3 mm2/s 
for lymphomas). In this study, no overlap was found in the ADC value for SCC and 
NHL and according to the ROC results, an ADC value of greater than 0.779 x 10-3 
mm2/s could be used to identify SCC, whereas an ADC value of less than 0.179 x 10-
3 mm2/s could be used to identify NHL, with 100% of specificity and sensitivity 
values. These thresholds may be beneficial in centers where the main differential 
diagnosis of malignant lymphadenopathy lies between these two cancers. 
The mean ADC ofNPC was found to lie between that of SCC and NHL, but in order 
to produce a clinically useful diagnostic tool (by setting a high specificity without too 
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much compromise of sensitivity) a threshold could only be found to determine NPC 
from NHL but not from SCC. 
In conclusion, the ADC values were significantly different between primary NPC, 
SCC and extra-nodal NHL. In a clinical setting, thresholds could be determined to 
distinguish SCC with a high ADC, from lymphoma with a low ADC. Thresholds 
could also be determined to distinguish NPC from NHL but not from SCC. 
3.3.5 Summary of DWI in Head and Neck Cancer 
Using the technique described in this thesis, DWI is found to be a feasible technique 
for examining head and neck cancers, even in the difficult site of the skull base. The 
ADC values of primary and nodal NPC have been documented (0.984 ± 0.161 x 10-3 
mm
2/s and 0.852 ± 0.117 x 10-3 mm2/s, respectively) and the single representative 
section measurement technique, which is quicker and easier to perform than the 
whole lesion measurement technique, has been shown to produce similar results in 
non necrotic tumors. The ADC value of NPC lies between that of SCC and NHL and 
the study has shown significant differences in the ADC of these three cancers. The 
study also shows that DWI can be used to produce clinically useful thresholds which 
may be helpful in distinguishing primary NPC from NHL but not from SCC. The 
results also confirm previous studies which show clinically useful differences 
between NHL and SCC. 
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Chapter 4: Chemical shift imaging of head and neck tumors 
4.1 Introduction - Single Voxel Spectroscopy and Chemical Shift 
Imaging 
Magnetic resonance spectroscopy is a non-invasive technique which provides 
information on cellular metabolism. Proton MRS (H-MRS) can detect a wide 
variety of proton-containing metabolites in tumors and has been used to evaluate 
cancers of brain, breast, prostate, colon, cervix, pancreas, ovary, and thyroid (lan C.P. 
Smith and Stewart, Laura C. , 2002; Shah, N. et aI., 2006). Previous MRS studies 
have shown that a common feature of many cancers is an increased choline-
containing compounds (Cho) level (Lee, 1. et aI., 2004). Cho appears to be elevated 
in squamous cell carcinoma of the head and neck (HNSCC) (Bisdas, S. et aI. , 2007; 
Maheshwari, S. R. et aI., 2000; Mukherji, S. K. et aI., 1997; Mukherji, S. K. et aI. , 
1996; Shah, N. et aI. , 2006) and is known to 1"e a constituent of the membrane lipids. 
In proliferating malignant tissue, elevated Cho level may serve as an active marker 
for cellular proliferation (Mukherji, S. K. and Gerstle, R. J., 1998) and the 
persistence of Cho may also serve as a biomarker for residual cancer in a post-
treatment mass (King, A. D. et aI. , 2009). The results of 'H-MRS studies using 
single voxel spectroscopy (SVS) to assess head and neck tumors have shown that IH_ 
MRS have some diagnostic value for the diagnosis and follow-up of disease 
processes as well as for the evaluation of physiological condition (Star-Lack, J. et af. , 
1998; Star-Lack, J. M. et aI., 2000; Wei Huang et aI. , 2000). However, this SVS 
technique has two main drawbacks. Firstly, SVS only produces a spectrum, rather 
than an image, and so is deemed less favorable in routine clinical practice. Secondly, 
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it provides little information regarding the spatial distribution of Cho in large 
heterogeneous lesions, which could be useful to guide biopsy or to identify recurrent 
disease following treatment. Chemical shift imaging (CSI), on the other hand, has 
the potential to overcome these drawbacks. CSI uses multi-voxel spectroscopy 
(MVS) technique to acquire spectra from multiple adjacent voxels and it can provide 
a much larger volume of interest (VOI) covering the whole lesion. Hence, CSI can 
generate images of the distribution and level of Cho metabolite within a large lesion, 
which could provide valuable information for treatment planning by directing higher 
does of radiation to these regions where Cho is most elevated. In addition, CSI is 
useful to examine cancer or post-treatment residual mass to display areas of high 
choline concentration, commonly referred to as "hot-spots". 
Proton chemical shift imaging (IH-CSI) has been established and applied to the brain, 
breast and prostate (Hermann, E. J. et a!., 2008; Hricak, H., 2005; Jacobs, M. A. et 
a!., 2004). Several brain studies using MVS technique have shown that it can be 
used to characterize gliomas based on changes in metabolite levels (De Stefano, N. et 
a!., 1998; Furuya, S. et aI., 1997; Hermann, E. 1. et a!., 2008). These studies have 
demonstrated that gliomas exhibit a reduction in N-acetylaspartate (NAA) and 
creatine (Cr), and an increase in choline (Cho), suggesting increased CholNAA andl 
or CholCr ratios associated with higher tumor grade. Because many gliomas are 
heterogeneous tumors, 1 H -CSI with choline hot spots are helpful to guide biopsy to 
find sites of high-grade tumor (McKnight, T. R. et a!., 2007; Son, B. C. et a!., 2001). 
I H -CSI has also been shown to be useful for the radiation treatment planning and 
follow-up of gliomas (Narayana, A. et a!., 2007; Nelson, S. J. et a!., 2002) as well as 
for the detection of recurrent disease and post-radiation changes (Narayana, A. et a!., 
2007; Sundgren, P. C. et al., 2009). For breast tumors, IH-MRS studies have shown 
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that increased Cho are generally detected by IH-MRS in breast cancers whereas in 
normal breast tissue and benign lesions, Cho are generally low and undetectable 
(Sardanelli, F. et aI., 2009). These findings can help to differentiate normal from 
abnormal breast tissue in patients with breast cancer. The first feasibility study of 
evaluating breast lesions with CSI technique was reported by Jacobs et. al. in 2004 
(Jacobs, M. A. et aI., 2004) and subsequent studies have confirmed that this CSI 
technique is applicable in a routine clinical setting (Baek, H. M. et aI., 2008). 
For prostate cancer, IH-MRS can detect changes in concentrations of citrate (Cit), 
creatine (Cr) and choline (Cho). Studies have shown that aggressive and higher 
grade tumors exhibit a relative augmentation of Cho level and reduction of Cit level, 
implying that the choline+creatine/citrate ratio ([Cho+Cr]/Cit) correlating with the 
Gleason grade can be helpful to predict prostate cancer aggressiveness (Swindle, P. 
et a!., 2003; Zakian, K. L. et a!., 2005). In clinical practice, combined MRI and IH_ 
CSI can be useful for the pretreatment assessment of prostate cancer aggressiveness 
(Hricak, H., 2005). 
In the head and neck region, single voxel 1 H:::MRS studies have demonstrated 
increased levels of choline and lactate in cancers (Bisdas, S. et a!., 2007; Mukherji, S. 
K. et a!., 1997; Star-Lack, 1. et a!., 1998). However, because of some inherent 
problems of performing CSI in the neck, this CSI technique has not been performed 
on head and neck tumors. The main challenges of performing CSI in the head and 
neck region are an inhomogeneous static magnetic field that affects the performance 
of CSI because of large susceptibility differences in the skull-base that cause 
difficulties in shimming. It is therefore necessary to develop a method to improve 
CSI, so that it can produce spectroscopy data of sufficiently high quality to allow it 
to be used as a research and clinical tool. 
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4.2 CSI - Methods Used to Reduce Magnetic Field Inhomogeneity 
Anti-susceptibility Device 
One method to improve magnetic field homogeneity in the head and neck region is 
placed by employing an anti-susceptibility device filled with a tissue-like material 
placed behind and around the neck (Figure 4.1). This type of device is usually 
known as sat pads filled with tissue-like material which has a magnetic susceptibility 
similar to that of human tissue. Some tissue-like materials that have magnetic 
susceptibility similar to human tissue (Schenck, J. F. , 1996) are listed in Table 4.1. 
Studies have demonstrated that water bags or sad pads filled with industrial grade 
silica (Si02) are useful to improve fat saturation in the air-tissue interface of the neck 
and to reduce the susceptibility-induced artifacts (R. M. Varek and C. Guclu, 2005), 
but at present they are not commercially available. On the other hand, sat pads filled 
with a liquid perfluorocarbon (PFC) (Sat Pad, Magmedix, Inc.) are commercially 
available and have been used to improve local magnetic field homogeneity and fat 
saturation of the neck and to improve the quality of MR images of the neck and 
" 
cervical spine (Choi, H. and Ma, J. , 2008). In this CSI study, sat pads filled with a 
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Magnet bore Anti-suscepti bi I ity device 
Figure 4.1: Illustration of an anti-susceptibility device used to improve magnetic 
field homogeneity in the head and neck region. 
Figure 4.2: The sat pads filled with liquid perfluorocarbon for the neck region. 
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Local Shim Method 
To reduce magnetic field inhomogeneities induced by the human body, the local field 
must be shimmed to produce a highly homogeneous magnetic field, a necessary 
condition for successful spectroscopy to be performed. During the shimming process, 
local shims are generally adjusted to optimize magnetic field homogeneity within the 
selected volume of interest (VOI). For each measurement situation, the effect of 
shimming can be very different on spectrum. Good shimming results in narrower 
line-width and bad shimming results in poor spectral resolution, and broadened 
spectral lines. 
Shimming can be performed using an iterative method or non-iterative method. 
Iterative shimming is an optimizing shimming procedure, which by iterative 
measurements look for the shim settings that provide the maximal amplitude of the 
time domain signal. Non-iterative shimming is a fast, automatic shimming procedure 
that explicitly uses the formalism of spherical harmonics to analyze the field 
inhomogeneity and to determine the shim settings, e.g. fast automatic shimming 
technique by mapping along projections (FA'STMAP) (Gruetter, R., 1993). In the 
F ASTMAP method, the pencil beam (PB) excitation will be used to measure the 
various orders of static magnetic field variations present in the studied region, and 
then the measured signal will be processed to estimate the amount of electrical 
current to be applied to the system shim and gradient coils to balance the local 
magnetic field variations in the studied region. 
Three shimming methods, such as iterative shimming, first-order shimming, and 
second-order shimming, were available on a 3T whole-body MR imaging system 
(Achieva 3T X-series; Phi lips Medical Systems, Best, the Netherlands). Iterative 
shimming was performed on the VOI, correcting magnetic field inhomogeneity with 
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the X, Y and Z linear components. The first-order and second-order shimming using 
pencil beam (PB) were also performed on the shim volume whose size is never 
smaller than 25 mm in every direction. The PB shimming can optimize magnetic 
field homogeneity with both first-order (X, Y, Z) and second-order (Z2, ZX, ZY, XV, 
X2 _ y2) shim corrections. 
4.3 Phantom studies - CSI Experiments Using Phantoms 
4.3.1 Introduction and Objectives 
In the MRS data acquisition process, sub-optimal shimming leads to spectral peak 
broadening and frequency shifts. Studies have shown that spectrallinewidth (full 
width at half maximum, FWHM) is even broaden at 3T compared to l.5T (Barker, P. 
B. et aI., 200 l). It is therefore necessary to develop a method to improve local 
magnetic field homogeneity to allow CSI in the head and neck. 
MRI test phantoms were built to objectively assess the improvement in spectral 
quality when using an anti-susceptibility device and shimming choices from the 
scanner. The objectives of this study were to test whether the use of an anti-
susceptibility device might improve local shimming so that reliable choline maps 
could be obtained in the head and neck. 
4.3.2 Methods 
Phantom Construction 
Three phantoms were fabricated, Phantom A (a bottle, 12 cm in diameter and 19 cm 
in height, Figure 4.3), Phantom B (a head-and-neck (HN) phantom simulating a 
regular size and shape of the human head, neck and shoulders, attached with an air-
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filled cylinder of 4.5 cm in diameter and 6 cm in length to mimic the nasal cavity and 
mouth and a small air-filled tube of 1.2 cm in diameter and 10 cm in length to mimic 
the human trachea, Figure 4.4) and Phantom C (a cylindrical bottle of 12 cm in 
diameter and 19 cm in height with four Cho samples of 1.2 cm in diameter and 4.7 
cm in length at a concentration of 10, 5, 2.5 and 1.25 millimolar (mM), Figure 4.5). 
All phantoms were filled with copper (11) sulfate (CUS04) doped water for shortening 
relaxation times. CUS04 (ReagentPlus TM, minimum 99%, Sigma-Aldrich, St. Louis, 
MO) was diluted in distilled water at a concentration of approximately 1 g/L. 
Glycerophosphocholine (GPC) (ChromaDex, lrvine CA) was used to prepare 






Figure 4.3: Phantom A. 
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Figure 4.4: Phantom B. 
Figure 4.5: Phantom C with choline samples. 
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4.3.3 Experiment and MR Protocol 
Experiment on Phantom A 
The aim of this experiment was to use a simple geometry to demonstrate the relative 
improvement in the line-width of water peak using Phantom A, in the presence and 
absence of an anti-susceptibility device (Figures 4.6 and 4.7). A VOI placed in the 
middle of Phantom A was used to evaluate the magnetic field homogeneity over 
Phantom A (Figure 4.8). 
Anti-susceptibility 
device 
Figure 4.6: Phantom A with an anti-susceptibility device. 



























Figure 4.8: A volume of interest within phantom A. 
Experiment on Phantom B 
Experiments with phantom B used a realistic head and neck structure to mimic the 
effects of air-tissues interface on magnetic field inhomogeneity. A VOI was placed 
within Phantom B to measure the magnetic field homogeneity over Phantom B 
(Figure 4.9) based on measurement of the line-width of the water peak. Experiments 
were performed with an anti-susceptibility device (Figure 4.10) and without device. 
Experiment on Phantom C 
The aim of this experiment was to perform CSI on four choline samples at different 
concentrations using four different shim volume sizes to produce Cho metabolite 
images from the samples. Phantom C containing 1.25, 2.5, 5 and 10 mM aqueous 
solution of choline (Cho) samples, was used to demonstrate the feasibility of 
performing CSI with the use of an anti-susceptibility device. Different sizes of shim 
volumes were used to demonstrate the effectiveness of the MRI scanner in obtaining 
a homogeneous magnetic field for a given volume of interest (VOI). In general, a 
larger VOI will be more difficult to shim compared to a smaller one. 
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VOI------..t 
Figure 4.9: A volume of interest (VOI) within phantom B. 
Figure 4.10: Phantom B with an anti-susceptibility device. 
56 
MRI Equipment and MRI Protocol 
All experiments were performed on a 3T whole-body MR imaging system (Achieva 
3T X-series; Phi lips Medical Systems, Best, the Netherlands). The MRI scanner was 
equipped with an 80 mT/m maximum gradient strength and a standard 16-channel 
N euro Vascular coil used for signal reception. All scans were done in one session 
without repositioning of the phantoms. 
MRI protocol consisted of a T1-weighted turbo spin-echo (T1 W TSE) sequence 
(repetition time = 360 ms, echo time = 10 ms, section thickness = 4 mm, with no 
intersection gap; number of signals acquired = two, flip angle = 90°, TSE factor = 4) 
to guide the positioning of volume of interest (VOI) for MRS. 
MRS Protocol for Experiments on Phantom A and B 
MRS on Phantoms A and B consisted of a point-resolved spectroscopic (PRESS) 
sequence with single voxel spectroscopy (SVS) technique (repetition time = 3000 ms, 
echo time = 288 ms, spectral bandwidth = 2000 Hz, number of signals acquired = 16, 
-' 
data samples = 1024). The VOI was placed in the iso-center of the MR scanner by 
setting the off-centre parameters to zero. A 2 x 2 x 2 cm3 shim volume was set to 
obtain spectra for evaluation. For each shimming method, the same MRS 
experiment was repeated up to five times (in the presence and/ or absence of an anti-
susceptibility device) to obtain sufficient experimental data to allow statistical 
analysis to be performed. 
CSI Protocol for Experiments on Phantom C 
CSI on Phantom C consisted of a PRESS-CSI sequence (repetition time = 2000 ms, 
echo time = 144 ms, the voxel size = 1 x 1 x 1 cm3, FOV = 24 cm, spectral bandwidth 
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= 2000 Hz, number of signals acquired = one, data samples = 1024). An automatic 
water suppression method provided by the scanners was employed. 
4.3.4 Data Analysis 
Phantom Measurements 
Data were reconstructed with the Philips data analysis package (Philips Medical 
Systems, Best, the Netherlands). All resonant peaks were analyzed using scanner's 
data processing workstation (ViewForum ™ R2.S.3, The Netherlands). The peak 
fitting procedure generated spectral data describing the peak heights, positions, areas 
and SNR, as well as producing color-coded metabolite maps and spectra of selected 
voxels. The water peak was set at 4.67 ppm and the Cho peak at 3.22 ppm (range, 
3.16 - 3.28 ppm) in the spectral fitting protocol. 
To evaluate the magnetic field homogeneity, spectral line-width was measured at the 
full width at half maximum (FWHM) in term of parts per million (ppm). The 
Larmor equation was used to convert the FWHM from Hz to ppm of the magnetic 
field strength, FWHM(ppm) == FWHM(Hz)/ 42.576Bo (T). The FWHM (ppm) 
defines the magnetic field inhomogeneity over the phantom volume (Joseph G. Och 
et al. , 1992). 
Statistical Analysis 
The percentage reduction in field inhomogeneity ( bBo ) was calculated by subtracting 
the mean water peak line-width after using the device from the mean water peak line-
width before using device and then dividing by the mean water peak line-width 
before using the device 
58 
A Wilcoxon signed rank test was employed to detect any statistically significant 
difference of the water line-width between before and after the use of an anti-
susceptibility device in the phantoms. A Friedman test was employed to detect any 
statistically significant difference of the water peak line-width among the three 
groups, first-order shimming, second-order shimming, and iterative shimming. If 
statistically significant difference (p <0.05) was obtained, a two-tailed non-
parametric Mann-Whitney U test was used to assess difference between each pair of 
these groups, and a p-value of less than 0.05 was considered to be statistically 
significantly different. Data were expressed as means ± standard deviation (SD). All 
statistical analyses were performed using SPSS, version 11.0 (SPSS, Chicago. Ill). 
4.3.5 Phantom Experimental Results 
Results from Experiments on Phantom A 
Results of the experiments using Phantom A (cylindrical phantom) are shown in 
Table 4.2. The mean line-width of water peak without an anti-susceptibility device 
was 3.94 ± 1.9 Hz. The mean line-width of the water peak with an anti-susceptibility 
device was 2.22 ± 0.32 Hz. Spectral line-width was significantly lower with an anti-
susceptibility device (p < 0.001, Wilcoxon signed rank test). The average reduction 
of the magnetic field inhomogeneity ( bBo ) was calculated about 43.7%. 
Three shimming methods were tested using Phantom A without using an anti-
susceptibility device. The mean line-widths and ranges of the water peaks were 
calculated and shown in the Table 4.3. When comparing first-order shimming, 
second-order shimming, and iterative shimming, statistical analysis showed that there 
was a statistically significant difference (p = 0.007, Friedman test) in terms of water 
peak line-widths among these three groups. When comparing each pair, the spectral 
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line-widths of second-order shimming were significantly lower than that of first-
order shimming (p <0.001) and iterative shimming (p = 0.001). The spectral line-
widths of iterative shimming were significantly lower (p = 0.002) than that of first-
order shimming (Figure 4.11, Table 4.4). 
These shimming methods were again tested using an anti-susceptibility device 
wrapped around Phantom A. The mean line-widths and ranges of the water peaks 
are shown in Table 4.5. By comparing the three groups of first-order shimming, 
second-order shimming, and iterative shimming, a statistically significant difference 
(p < 0.001, Friedman test) was found among them. When comparing each pair, the 
spectral line-widths of second-order shimming were significantly lower than that of 
first-order shimming (p <0.001) and iterative shimming (p < 0.001), and the spectral 
line-widths of iterative shim were significantly lower (p = 0.001) than that of first-
order shim (Figure 4.12, Table 4.6). The second-order shimming method produced 
the narrowest water peak line-widths compared with other shimming methods 
whether an anti-susceptibility device was used or not. 
Water peak line-width (Hz) 
Without 
Phantom AI Statistical values Device With Device 
~ean 3.94 2.22 
standard deviation (SD) 1.9 0.32 
Range 1.53 - 6.13 1.66 - 2.81 
Number of scan 27 40 
Reduction of the field 
inhomogeneity (bEo) 43.7% 
p-value <0.001 
Table 4.2: Comparison of Phantom A with and without device. 
60 
Mean water peak line-
Phantom A Without Device/ Method width ± SD (Hz) Range (Hz) 
First-order shimming (n = 10) 5.98 ±0.08 5.88-6.13 
Second-order shimming (n = 12) 1.94 ±0.21 1.53-2.17 
Iterative shimming (n = 5) 4.67 ±0.35 4.22-5.11 
Table 4.3: Phantom A without device, mean weak peak line-width ± standard 
deviation (SD) and range. 
Mann-Whitney U test for Phantom A without device 
Comparison p-value 
First-order shim versus Second-order shim <0.01 
Second-order shim versus Iterative shim 0.001 
First-order shim versus Iterative shim 0.002 
Table 4.4: Comparison of shimming techniques for Phantom A without device. 
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Shim Type 
Figure 4.11: A scatter plot of Phantom A without device: Water peak line-width 
versus different shim types. 
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Mean water peak line-
Phantom A With Device/ Method width ± SD (Hz) Range (Hz) 
First-order shimming (n = 16) 2.54 ±0.15 2.30-2.81 
Second-order shimming (n = 16) 1.90 ±0.12 1.66-2.04 
Iterative shimming (n = 8) 2.24 ±0.15 2.04-2.55 
Table 4.5: Phantom A with mean weak peak line-width ± standard deviation 
(SD), range, number of scan (n), reduction of the field inhomogeneity ( bEo ) 
and p-values. 
Mann-Whitney U test for Phantom A with device 
Comparison of shimming techniques p-value 
First-order shim versus Second-order shim <0.001 
Second-order shim versus Iterative shim <0.001 
First-order shim versus Iterative shim 0.001 
Table 4.6: Comparison of shimming techniques for Phantom A with device. 
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Figure 4.12: A scatter plot of Phantom A with device: Water peak line-width versus 
different shim types. 
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Results from Experiments on Phantom B 
Phantom B, designed to mimic the large susceptibility differences in the head and 
neck, was tested with and without an anti-susceptibility device while undergoing 
MRS experiments (Table 4.7) and the mean line-width of water peak when an anti-
susceptibility device was used was 4.9 Hz. Spectral line-width of water peak was 
significantly lower with an anti-susceptibility device (p < 0.001, Wilcoxon Signed 
Rank test). After the use of an anti-susceptibility device in Phantom B, the average 
reduction of the magnetic field inhomogeneity ( bEo ) was about 570/0. 
Without using an anti-susceptibility device, the three shimming methods were tested 
using Phantom B. The mean line-widths and ranges of the water peaks obtained are 
shown in Table 4.8. When comparing the three shimming methods (first-order 
shimming, second-order shimming and iterative shimming), statistical analysis 
demonstrated that there was a statistically significant difference (p = 0.007, Friedman 
test) among them. When comparing each pair, the mean water peak line-widths of 
second-order shimming were significantly lower than that of first-order shimming (p 
--
< 0.001) and iterative shimming (p = 0.002), and the mean line-widths of first-order 
shimming were significantly lower (p = 0.003) than that of iterative shimming 
(Figure 4.13, Table 4.9). 
These three shimming methods were again tested using Phantom B together with an 
anti-susceptibility device. The mean line-widths and ranges of the water peaks are 
shown in Table 4.10. When comparing first-order shimming, second-order 
shimming, and iterative shimming, a statistically significant difference (p = 0.001 , 
Friedman test) was found among them. When comparing each pair, the mean water 
peak line-widths of second-order shimming were significantly lower than that of 
first-order shimming (p < 0.001) and iterative shimming (p < 0.001). The spectral 
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line-widths of iterative shimming were significantly lower (p= 0.011) than that of 
first-order shimming (Figure 4.14, Table 4.11). The second-order shimming 
produced the narrowest line-widths compared to other shimming methods. 
Water peak line-width (Hz) 
Without 
Phantom B/ Statistical values Device With Device 
Mean 11.4 4.90 
Standard deviation (SD) 6.34 2.29 
Range 4.22 - 18.27 1.79 - 7.15 
Number of scan (n) 24 35 
Reduction of the field 
inhomogeneity ( &30 ) 57.0% 
p-value <0.001 
Table 4.7: Comparison of Phantom B with and without device. 
Mean water peak line-
Phantom B Without Device/Method width ± SD (Hz) Range (Hz) 
First-order shimming (n = 8) 16.5 ±0.36 15.97-16.99 
Second-order shimming (n = 11) 4.67 ±0.38 4.22-5.36 
Iterative shimming (n = 5) 18.0 ±0.25 17.63-18.27 
Table 4.8: Phantom B without device, mean weak peak line-width ± standard 
deviation (SD) and range. 
Mann-Whitney U test for Phantom B without device 
Comparison p-value 
First-order shim versus Second-order shim <0.001 
Second-order shim versus Iterative shim 0.002 
First-order shim versus Iterative shim 0.003 
Table 4.9: Comparison of shimming techniques for Phantom B without device. 
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Phantom B Without Device: Water peak line-width versus different shim types 
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Figure 4.13: A scatter plot of Phantom B without device: Water peak line-width 
versus different shim types. 
Phantom B With Device/Shim Type 
First-order shimming (n = 14) 
Second-order shimming (n = 14) 
Mean water peak line 






Iterative shimming (n = 7) 6.53 ±0.17 6.26-6.77 
Table 4.10: Phantom B with device, mean weak peak line-width ± standard 
deviation (SO) and range. 
Mann-Whitney U test for Phantom B with device 
Comparison of shimming techniques p-value 
First-order shim versus Second-order shim <0.001 
Second-order shim versus Iterative shim <0.001 
First-order shim versus Iterative shim 0.011 
Table 4.11: Comparison of shimming techniques for Phantom B with device. 
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Figure 4.14: A scatter plot of Phantom B with device: Water peak line-width versus 
different shim types. 
Results from Experiments on Phantom C 
CSI experiments were using Phantom C whi9h contained 1.25, 2.5, 5 and 10 mM 
Cho samples. Results obtained for PB auto second order shimming demonstrated the 
feasibility of performing CSI with different shim volumes, such as 8x8x 1 cm3 
(Figure 4.15), 7x7x 1 cm3 (Figure 4.16), 6x6x 1 cm3 (Figure 4.17), and 5.5 x5.5 x l 
cm
3 (Figure 4.18). 
The colour-coded images showed that hot spots in yellow represented a relatively 
high Cho signal compared to the cold spot in orange. 
Cho maps were correctly produced where Cho samples were placed. The spectral 
line-widths measured from the 10 mM Cho sample spectra obtained from different 
shim volumes showed that as shim volume was reduced, there was a corresponding 
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reduction in the peak line-width (Table 4.12) without marked changes in the peak 
SNR. 
Line-width of a 10 mM 
Shim volume size choline solution Signal-to-noise ratio (SNR) 
SxSx1 cm3 10.60 Hz 10S 
7x7x1 cm3 10.22 Hz 127.7 
6x6x1 cm3 9.S4 Hz 125.2 
5.5x5.5x1 cm3 9.45 Hz 106 
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Figure 4.16: Phantom C with VDI of 7 x7 x 1 cm . 
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Figure 4.18: Phantom C with VOI ofS.S xS.S x1 cm . 




Spectral line-widths obtained before and after the use of an anti-susceptible device 
filled with liquid perfluorocarbon (PFC) in the phantom studies showed that the 
device could significantly reduce magnetic field inhomogeneities and improve 
spectral resolution. Liquid PFC is a non-protonated substance that does not generate 
any proton signal in proton MRI and has a magnetic susceptibility similar to human 
tissues. Hence, the device has been used to improve fat saturation of the neck and 
quality ofMR images. 
By comparing the line-width of the water peaks obtained from experiments without 
using an anti-susceptibility device, a relatively large standard deviation was noted. 
This large standard deviation indicated a large variability and uncertainty in 
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obtaining consistent results from all three shimming methods tested. When 
employing the anti-susceptibility device, the spectral line-widths became much 
narrower with a smaller standard deviation. The device groups appeared to yield 
more consistent results from the three shimming methods tested. This effect can be 
explained by the fact that the anti-susceptibility device filled with the outer air spaces 
of the phantoms such that susceptibility effects were reduced. Hence, the use of an 
anti-susceptibility device could improve the local magnetic field homogeneity and 
enables reliable CSI to be performed, demonstrated by narrow peak line-widths. 
Effectiveness of the iterative, first-order and second-order shimming methods were 
tested using phantoms, and the spectral line-widths of water peak obtained were 
compared. In experiment using a cylindrical bottle, these three shimming methods 
could produce relatively narrow line-widths in a given VOI. This was probably 
because the geometry of the cylindrical bottle, being in a cylindrical shape and with 
no air gap, the susceptibility effects of the phantom on the local magnetic field 
homogeneity were minimal. Hence, these three shimming methods could produce 
narrow line-widths. 
However, the spectral line-widths obtained from a human-sized head and neck 
phantom designed and constructed for this research indicated significant differences 
among different shimming methods. The spectral line-widths of iterative and first-
order shimming were greater than that of the second-order shimming. This meant 
that iterative and first-order shimming could not reduce field inhomogeneity as 
effective as second-order shimming, and thereby leading to a much broader line-
width. This line-width broadening occurred because of inadequate shimming, 
leading to inhomogeneities in the local magnetic field during data acquisition. 
Magnetic field inhomogeneity was more severe in the head and neck phantom than a 
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cylindrical bottle due to the geometry of the phantom, and presence of air within the 
phantom. Hence, first-order and iterative shimming seemed to be an insufficient 
method to correct local field inhomogeneities in the head and neck phantom. 
Second-order shimming, on the other hand, could effectively reduce field 
inhomogeneity created by the head and neck phantom, producing a much narrower 
peak line-width. 
To minimize motion artifacts during CSI data acquisition, a short scan time is 
essential. The total execution time for PB-shimming (first-order and second-order 
shimming) and iterative shimming are approximately 30-40 seconds and 4-5 minutes, 
respectively, with the exclusion of the time required for water and/or fat suppression. 
PB-shimming could provide a shorter total scan time than iterative shimming, and 
therefore, PB-shimming may be used to minimize motion artifacts in CS!. 
This study also showed that shimming a larger VOI is more challenging than 
shimming a smaller one. A large VOI could create difficulties in shimming, leading 
to broadened line-widths in CSI or study failure. In the phantom studies, CSI was 
..-
performed with different shim volumes on a bottle phantom containing choline 
samples. Data from this study showed that the spectral line-width of a 10 mM 
choline solution became smaller with decreasing shim volume. These results suggest 
that shimming a smaller volume could result in a more homogeneous local magnetic 
field and better spectral resolution. 
Results from CSI experiments also showed that Cho at low concentration such as 
1.25 and 2.5 mM may not be readily detectable. U ndetectable Cho could also be due 
to partial volume contamination or the effect of voxel bleeding, which is referred to 
signal contamination from adjacent spectroscopic voxels. Metabolite spectra within 
such a voxel would exhibit contamination by signals from surrounding voxels. To 
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minimize partial volume effects, carefully positioning smaller voxels within ROI 
might be helpful. 
Experimental data from this work strongly supports the notion that an anti-
susceptibility device filled with liquid PFC could significantly improve the local 
magnetic field homogeneity. Results from this work indicated the best local 
magnetic field homogeneity in the phantoms could be achieved when using an anti-
susceptibility device together with PB-auto second-order shimming. Local 
shimming could be further improved by shimming a relatively smaller volume of 
interest, which implies that selecting a shim volume matching the dimensions of the 
lesion of interest could significantly increase the likehood of a successful CSI study. 
4.4 In vivo CSI Study of Human Head and Neck Tumors 
4.4.1 Introduction and Objectives 
Proton chemical shift imaging (I H -CSI) has been successfully used to detect elevated 
choline containing-compounds (Cho) in different cancers, but because of inherent 
problems of performing CSI in the head and neck region, this technique has not been 
applied in the study of head and neck tumors. In this project, phantom based 
experiments have identified the conditions under which CSI may be performed in the 
head and neck where large susceptibility differences have a negative effect On local 
magnetic field homogeneity. The objectives of this part of the CSI study were to 
apply the methods learned from phantoms studies on patients with head and neck 
tumors in vivo. 
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4.4.2 Patient Selection 
Consecutive patients with newly diagnosed head and neck tumors were recruited for 
this prospective study. The research ethics committee approval was obtained and an 
informed consent was also obtained from all patients before the study. Thirteen 
patients with head and neck tumors underwent both MRI and CSI examinations 
between November 2008 and March 2009. Histological and imaging findings were 
the reference standard for the head and neck tumors. 
4.4.3 MRI and CS! Protocol 
All examinations were performed on a 3T whole-body MR imaging system (Achieva 
3T X-series; Philips Medical Systems, Best, the Netherlands). The MRI scanner was 
equipped with an 80 mT/m maximum gradient strength for MRI. A 16-channel 
Neuro Vascular coil was used to obtain high-quality images to include tumors arising 
from the upper aerodigestive tract. An anti-susceptibilities device filled with liquid 
perfluorocarbon (PFC) (Sat Pad, Magmedix, Inc.) was used to improve the local 
magnetic field homogeneity in the head and neck tumor patients. 
MRI images were used to help defining the volumes of interest (VOI) to include the 
region of interest (ROI) for CS!. MRI sequences included an axial Tl-wieghted 
turbo spin-echo (Tl W TSE) sequence (repetition time = 540 ms, echo time = 10 ms, 
section thickness = 4mm, with no intersection gap, acquisition matrix = 512 x352, 
number of signals acquired = 2), an axial T2-wieghted fat-suppressed (T2W FS) 
sequence (repetition time = 4455 ms, echo time = 80 ms, section thickness = 4 mm, 
with no intersection gap acquisition matrix = 364 x 262, number of signals acquired 
= 2). 
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CSI was performed on a single slice using a two-dimension point-resolved 
spectroscopic sequence (2-D PRESS) for volume selection (repetition time = 2000 
ms, echo time = 144 ms, voxel size = 1 x 1 x 1 cm3, FOV = 24 cm, number of signals 
acquired = 1, spectral bandwidth = 2000 Hz, data samples = 1024). PB-auto second 
order shimming was used to optimize the local magnetic field homogeneity for CS!. 
4.4.4 Data Analysis 
CSI data were analyzed using the Philips data analysis package (Philips Medical 
Systems, Best, the Netherlands). The water peak was referenced at 4.67 ppm, Cho 
peak at 3.22 ppm (range, 3.15 - 3.27 ppm) and the fatty acids peaks (0.9 - 1.3 ppm) 
from methylene group at 0.9 ppm and methyl group at 1.3 ppm. 
Head and neck tumor measurements, such as minimum axial diameter, maximum 
axial diameter and area of lesion, were also recorded. Statistical data were expressed 
as the mean plus or minus the standard deviation (SD). 
4.4.5 Resultsfrom CS! on Patients 
CSI was performed on 13 head and neck tumors which showed an average maximum 
axial diameter of 3.73 ± 1.67 cm (range, 1.86 - 8.57 cm), average minimum axial 
diameter of2.36 ± 0.89 cm (range, 1.32 - 4.65 cm), and average area of7.51 ± 6.19 
cm2 (range, 1.27 - 25.91 cm2). CSI was unsuccessful in four cases due to patient 
movement and susceptibility artifacts (primary NPC, n = 2; tonsil SCC, n = 1; hard 
palate mucoepidermoid carcinoma (MECa), n = 1). CSI was successful in producing 
choline maps showing the distribution of choline-containing compounds (Cho) in 
nine patients, hence, the success rate of performing CSI was calculated to be 69% 
(9/13) in this pilot CSI study. The nine patients comprised of eight men and one 
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woman aged between 26 and 55 years of age (mean age ± standard derivation = 48 ± 
9) with 9 head and neck tumors (undifferentiated nasopharyngeal carcinoma (NPC) 
lymph node metastasis, n = 5; squamous cell carcinoma (SCC) lymph node 
metastasis, n = 2; benign Schwannoma, n = 2). Table 4.13 summarizes the patent 
demographics, lesion characteristics, and CSI results. The average of Cho SNR was 
5.26 ± 2.60 (range, 2.3 - 9.48), and the average line-width ofCho was 15.4 ± 5.68 
Hz (range, 7.41 - 25.5 Hz). Lipids (at 0.9 and 1.3 ppm) were also present in the 
spectra. 
Figure 4.19-22 show four examples of successful CSI, the corresponding MR images 
and selected spectra from the head and neck tumors of four patents. Elevated Cho 
were apparent within the CSI images; their SNR were sufficient for data analysis and 
interpretation. The shim volume was used to optimize the magnetic field 
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Figure 4.19: MRI and CSI images ofa 41-year-old patient (subject 1) with a 
metastatic node of SCC. The elevated choline "hot-spot" (range of SNR Cho, 2.6 -
6.9) was correctly produced where the lesion was located as shown by conventional 
MR images. The spectrum as shown was selected from the yellow voxel found 
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Figure 4.20: MRI and CSI images of a 50-year-old patient (subject 2) with a 
metastatic node ofNPC. The elevated choline "hot-spot" (range of SNR Cho, 2.5 -
19.5) was correctly produced where the lesion was located as shown by conventional 
MR images. The spectrum as shown was selected from the yellow voxel found 
within the shim volume and choline signal from that voxel had a SNR of 11.4. 
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d 
Matab Position SNR Width Height Area 
Cho 3.222 16.5 0.146 1.746 0.285 
1 S 
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Figure 4.21: MRI and CSI images ofa 52-year-old patient (subject 4) with a 
metastatic node of NPC. The superior part of the tumor had elevated Cho signals 
(range of SNR Cho, 4.8 - 16.5) compared wjth the inferior parts of the lesion. The 
spectrum as shown was selected from the yellow voxel found within the shim 
volume. The choline signal from that voxel had a fairly narrow line-width 
(suggesting good shimming was achieved) and a high SNR (16.5). 
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d e 
Matab Position SNR Width Heig,t .Area 
Cho 3 .201 3.2 0 .090 0.429 0.043 
Matab Postion SNR Width Heig,t .Area 
Cho 3 .226 9 .7 0 .091 1.247 0 .127 
Position SNR Width Height .Area Matab Position SNR W1dth Height .Area 
3 .220 11 .6 0 .090 1.177 0.118 Cho 3.201 3.2 O .O~ 0.429 0 .043 
Figure 4.22: MR and CSI images of a 26-year-old patient with benign Schwannoma 
(Subject 6). The elevated choline "hot-spot" was apparent in this benign tumor as 
shown by conventional MR images. The spectra as shown were selected from the 
yellow voxels found within the shim volume and choline signals from selected 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.4.6 Discussion and Conclusion 01 CS] on Patients 
Detection of choline signal in human neck lesions with CSI has not been previously 
reported, although prior studies have been successfully performed using single-voxel 
(SV) MR spectroscopy (King, A. D. et aI., 2004; King, A. D. et aI., 2005a; King, A. 
D. et aI., 2005b; King, A. D. et aI., 2005c; Mukherji, S. K. et aI., 1996; Star-Lack, 1. 
et aI. , 1998; Wei Huang et aI., 2000). The result of this study showed that CSI is 
feasible in the study of human head and neck tumors when using an anti-
susceptibility device filled with liquid perfluorocarbon (PFC) and appropriately 
selected shimming method. High quality choline maps depicting the distribution of 
choline-containing compounds (Cho) in large heterogeneous tumor within acceptable 
scanning time have been shown to be feasible. 
This CSI study extended the previous work done with SV methods and demonstrated 
the feasibility of using CSI to study head and neck tumors. One of the prior studies 
investigated seven patients with SV lHMRS and found elevated Cho in all patients 
with histologically proved squamous cell carcinoma (SCC) of the upper 
aerodigestive tract (Mukherji, S. K. et al., 1997). Another studies also detected Cho 
in lymph node metastasis (Chawla, S. et al., 2009; Star-Lack, 1. M. et aI., 2000) and 
malignant tumors(Wei Huang et al., 2001). Elevated Cho is found not only in 
malignant neoplasm, but also in benign neoplasm that is hyper-cellular and in 
inflammatory processes. In vitro studies at 11 T found elevated Cho in benign tumors 
of the head and neck, including glomus tumors, inverting papillomas and 
Schwannoma (Maheshwari, S. R. et al., 2000). In vivo studies at 1.5T showed the 
detectable Cho signals in benign tumors and benign lymphoid hyperplasia (Bisdas, S. 
et aI., 2007). In this CSI study, elevated Cho were found in metastatic lymph nodes 
81 
and benign and malignant tumors and their Cho distributions were apparent within 
the CSI images. 
This in vivo CSI study was performed on a clinical 3T scanner. Generally, higher 
field strength, such as 3T, compared with conventional 1.5 T should provide better 
signal-to-noise ration (SNR), since the SNR is directly proportional to the magnetic 
field strength. In MRI, the advantage of better SNR can be used to improve spatial 
resolution and reduce acquisition times. In MR spectroscopy, higher field strength 
would provide greater SNR and better spectral resolution. However, the 
susceptibility effects increase with higher field strength, and thereby leading to lower 
magnetic field homogeneity over the studied region. In vivo MRS studies have 
shown that the line-widths were even broader at 3 T than at 1.ST (Barker, P. B. et aI., 
2001). Hence, the use of 3T or above will increase variability in the homogeneity of 
the magnetic field over the VOI, particularly a large one. 
In this study, several strategies were adopted to improve local magnetic field 
homogeneity. One effective way to improve local magnetic field homogeneity was 
to use an anti-susceptibility device filled with liquid PFC that has a magnetic 
susceptibility similar to human tissue. Alternative materials could potentially be 
used to improve magnetic field homogeneity. The use of water bags behind and 
around the neck is an inexpensive way to reduce susceptibility artifacts and improve 
magnetic field homogeneity. Water bags, however, would produce a large amount of 
unwanted bright signal surrounding the neck, which may be distracting for viewing 
T2W images. In the CSI data acquisition, any minimal motion of this vast water 
signal in the phase-encoding direction will immediately induce artifacts in CSI 
(Rosen, Y. et aI., 2007). Hence, because of artifacts induced by the water movement 
in the water bags, the use of water bags may be less effective for CS!. Other 
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materials that have the magnetic properties similar to human tissues include silica 
(Si02), alumina (AI20 3) and magnesia (MgO). These materials are non-protonated 
substances that could be potentially used to improve magnetic field homogeneity. 
The silica-based pads filled with industrial grade silica have been shown to reduce 
susceptibility-induced artifacts and improve fat saturation of the neck (R. M. Varek 
and C. Guclu, 2005). Comparing the effectiveness of different materials in 
improving local magnetic field homogeneity was beyond the scope of the present 
study and future studies may be necessary to further improve the current method 
using better materials. 
Higher-order shimming was shown to be necessary to correct magnetic field 
inhomogeneities over the VOI in the head and neck. Local field inhomogeneity may 
be more complex in the head and neck than the brain due to variations in 
susceptibility and the geometry of the neck. Higher-order shimming, such as second-
order shimming, proved to be an effective means to reduce local field inhomogeneity 
over a large VO!. Shimming a smaller volume that matches the approximate 
dimensions of the heterogeneous lesion is another strategy that allows CSI to be 
performed successfully. Local shimming is less demanding when the shim volume is 
smaller but the downside is that CSI may not be feasible if lesions are widely spread 
or located bilaterally. 
Despite the encouraging results of this prospective study, there are limitatioris on 
applying CS!. In this CSI study, spectra were uninterpretable in four cases when the 
tumors were located near the tongue and jaw bone (mandible) (Figure 4.23), 
nasopharynx (Figure 4.24), skull base (Figure 4.25), and hard palate (Figure 4.26). 
Susceptibility differences in these regions may be very large causing artifacts in the 
spectra, thereby rendering interpretation more difficult. Hence, tumors in regions of 
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large susceptibility differences are difficult to evaluate with CS!. Evaluation of head 
and neck tumors in these difficult regions may, therefore, rely on SV MRS, which is 
less prone to susceptibility problems. Other possible factors , which could cause 
difficulties in CSI, were patient movements, such as breathing, swallowing and 
dental implants. 
There are other technical limitations that require attention when performing CSI in 
the head and neck on patients. Firstly, CSI was only tested using a single slice only, 
due to the fact that the time required for the study must be reasonably short. 
Secondly, small shim volume means that lesions that are too large may not be 
properly studied or may leave other suspicious tissue uninvestigated (Figure 4.27). 
In conclusion, this in vivo CSI study demonstrated that proton CSI of the head and 
neck is feasible with the use of an anti-susceptibility device filled with liquid PFC, 
and that metabolic mapping of Cho is promising for the non-invasive identification 
of head and neck tumors. Good quality spectra may be difficult to obtain near 
nasopharynx, skull base, and hard palate due to high susceptibility differences. CSI, 
therefore, may have the potential to guide biopsies of head and neck tumors as well 
as may be useful for characterization of head and neck lesions. 
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Figure 4.23: MRI images of a 59-year-old patient with SCC (subject 10). 
Figure 4.24: MRI images of a 70-year-old patient with NPC (subject 11). 
Figure 4.25: MRI images of a 53-year-old patient with NPC (subject 12). 
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Figure4.26: MRI images of a 40-year-old patient with MECa (subject 13). 
Figure 4.27: MRI images of a 53-year-old patient with NPC node (subject 3). 
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Chapter 5: Summary, conclusion and future studies 
5.1 Summary 
DWI and CSI are MRI techniques that both show great potential for examining head 
and neck tumors, but they both can be difficult to perform in the head and neck due 
to technical problems including susceptibility artifacts. The results of this thesis 
show that these technical problems can be overcome and the main findings are 
summarized as follows: 
DWI 
• By employing six b values up to 500 s/mm2, such as 100, 200, 300, 400 and 
500 s/mm2, DWI is feasible for examining head and neck cancers, even at 
sites that suffer from susceptibility artifacts such as the skull base; 
• This study further documented the ADC values of primary NPC and nodal 
metastases (0.984 ± 0.161 x 10-3 mm2/s and 0.852 ± O.l17 x 10-3 mm2/s, 
respectively); 
• The results have showed that using the single representative section technique 
for ADC measurement in non necrotic lesions can produce results similar to 
using the whole lesion technique; 
• The results have also showed that the ADC value ofNPC lies between that of 
SCC and NHL and this study has indicated significant differences in the ADC 
of these three cancers, suggesting that ADC measurement may be useful in 
the characterization of head and neck cancers; 
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• This study also indicates that DWI with ADC measurement can be used to 
produce clinically useful thresholds which may be helpful in distinguishing 
primary NPC from NHL but not from SCC; 
• The results also confirmed previous studies which show clinically useful 
differences between NHL and SCC. 
CSI 
• For CSI, the data provided in this study strongly supports the notion that an 
anti-susceptibility device filled with liquid PFC could significantly improve 
the local magnetic field homogeneity; 
• The results indicated that the best local magnetic field homogeneity in the 
phantoms could be achieved when using an anti-susceptibility device filled 
with liquid PFC, together with PB-auto second-order shimming; 
• The results also indicated that local shimming could be further improved by 
shimming a relatively smaller volume of interest, which implies that selecting 
a shim volume that matches the dimensions of the lesion of interest could 
significantly increase the likehood of a successful CSI study; 
• This study shows that metabolic mapping of Cho is feasible and is a 
promising non-invasive tool for evaluating head and neck tumors; 
• However, good quality spectra may be difficult to obtain near nasopharynx, 
skull base, and hard palate due to high susceptibility differences. 
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5.2 Conclusion 
DWI is a feasible technique for examining head and neck cancers, even at the site of 
the skull base. To measure ADC value within non-necrotic lesions in the head and 
neck, the single representative section technique is preferred. The results showed 
that ADC values were significant difference among primary NPC, SCC and extra-
nodal NHL, suggesting that the ADC measurements may be useful in the 
characterization of head and neck cancer. For CSI, to the best of my knowledge, the 
results from this pilot study are the first to demonstrate the feasibility of performing 
CSI in the head and neck to show metabolic mapping of Cho in head and neck 
tumors. This information has the potential to detect cancer and guide biopsies. 
5.3 Future Studies 
Future research is needed in this area, particular concerning a large study group of 
patients with head and neck lesions, developing techniques further and identifying 
potential clinical applications. In this study, D WI showed the capability to 
characterize the ADC of NPC, so that future studies need to assess the changes in 
tumor ADC after therapy as well as evaluate the role ofDWI in monitoring the 
response to treatment. For CSI of the head and neck, this technique is feasible with 
the use of an anti-susceptibility device filled with liquid PFC, so that future studies 
need to further improve the current method using better materials and/ or protocols 
(e.g. turbo spectroscopic imaging (TSI) and SENSE). Another direction for future 
studies is to evaluate the diagnostic ability of CSI in the detection and localization of 
head and neck cancer, prospectively compared with histopathologic findings as well 
as to assess the role of CSI in monitoring the effects of treatment in patients with 
head and neck cancer. 
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